Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2015

Concordance of Genotyping and Phenotyping in
the Classification of Methicillin-Resistant
Staphylococcus Aureus
Ali M. Bazzi
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Public Health Education and Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.

Walden University
College of Health Sciences

This is to certify that the doctoral dissertation by

Ali Mohamad Bazzi

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.

Review Committee
Dr. Maria Rangel, Committee Chairperson, Public Health Faculty
Dr. Aimee Ferraro, Committee Member, Public Health Faculty
Dr. Patrick Tschida, University Reviewer, Public Health Faculty

Chief Academic Officer
Eric Riedel, Ph.D.

Walden University
2015

Abstract
Concordance of Genotyping and Phenotyping in the Classification of MethicillinResistant Staphylococcus Aureus

by
Ali M. Bazzi

MSc, Arabian Gulf University, 2006
BSc, Lebanese University, 1993

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Public Health

Walden University
November 2015

Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) strains have spread in Saudi Arabia,
increasing morbidity, mortality, and financial burdens. Recent studies have suggested the
phenotyping methods typically used to classify MRSA as either health care MRSA (HAMRSA) or community-associated MRSA (CA-MRSA) cases are unreliable, because they
lack concordance with the results of genotyping. Yet the expense associated with
genotyping precludes its use in the Saudi Aramco population in Saudi Arabia. The
absence of a standardized and affordable method to classify MRSA into CA-MRSA and
HA-MRSA has been a challenge for infection control programs in Saudi Arabia. The
objective of this quantitative, secondary data analysis was to determine the most reliable
phenotyping approach to strain identification using stored samples from John Hopkins
Aramco Hospital. The ecological and antibiotics selection pressure theories framed this
research. The results of concordance, and sensitivity and specificity tests, suggested
hospital admission profiles and susceptibility pattern were the most reliable phenotypic
predictors of genotype-based classifications. Multiple logistic regression for
susceptibility pattern (OR = 15.47, p < .001) and hospital admission profile (OR = 2.87, p
= .008) confirmed those results, whereas all other variables were not found to be
statistically significant. These results can be used to clarify the epidemiological and
molecular factors that affect the transition of MRSA from health care facilities to the
Saudi Aramco community. Implications for positive social change include faster and
more reliable classification of MRSA to aid in disease surveillance and the selection of
appropriate treatments to reduce MRSA-related morbidity and mortality.
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Chapter 1: Introduction to the Study
In the early 1960s, Methicillin-resistant Staphylococcus aureus (MRSA) strains
were first isolated from patients exposed to health care risk factors such as
hospitalization, surgery, dialysis, and indwelling devices (David et al., 2006). Like
infection by other multidrug resistant organisms, MRSA infection increases patients’
morbidity and mortality risk and health care costs (Centers for Disease Control and
Prevention, 2013a). From the mid-1970s through the 1990s, the incidence of MRSA in
health care settings dramatically increased (Panlilio et al., 1992). MRSA cases that were
isolated within health care settings or from those who received recent care from such
settings are referred to as health-care-associated MRSA (HA-MRSA). Then, in the late
1990s, a new strain of MRSA without health care risk factors was isolated. This new
MRSA strain shares genetic background with Staphylococcus aureus. However, it has a
distinct genetic code that had not previously existed (David et al., 2006). The new MRSA
strains identified among individuals outside of health care settings and those who have
not received recent care from such settings is referred to as community-associated MRSA
(CA-MRSA).
CA-MRSA has been a growing problem with increasing incidence and prevalence
in Saudi Arabian communities, and it has migrated into health care settings (Bukharie,
2010). Besides having resistant genes, CA-MRSA is known to acquire toxin-producing
genes such as Panton-Valentine leukocidin (PVL). PVL is lethal to white blood cells and
can cause tissue necrosis including necrotizing pneumonia in young patients (Gillet et al.,
2002). Phenotyping and genotyping methods have been used to classify strains.
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Phenotyping methods classify strains as HA or CA based the organism’s observed
characteristics, such as health care risk factor classification, infection type classification,
and susceptibility pattern classification. Genotyping methods that classify strains using
the organism’s genetic code include pulsed field gel electrophoresis (PFGE) and
polymerase chain reaction (PCR). However, phenotyping methods have become less
reliable due to the increased incidence of CA-MRSA in health care settings and the
continuous rise in antibiotic resistance among CA-MRSA strains (McCarthy et al., 2010).
Several studies have demonstrated that CA-MRSA strains originating from
patients with no antecedent hospital exposure were clonally distinct from hospital
endemic MRSA strains (Naimi et al., 2013; Vandenesch et al., 2003). The apparent
phenotypic and genotypic differences between CA-MRSA and HA-MRSA were noted in
anecdotal reports, case series, and outbreak studies, which often compared few CAMRSA strains to historical HA-MRSA control isolates from worldwide collections
(Enright et al., 2002; Vandenesch et al., 2003). Such comparison of contemporary cases
to historical controls is flawed, as it does not allow for elimination of potential biases due
to other factors that may have changed over time (e.g., clonal shifts). Thus, concurrent
molecular genetic characterization of MRSA strains combined with well-designed
epidemiologic studies will enable the identification of the transmission dynamics of CAMRSA and HA-MRSA.
The aim of this study was to assess the molecular characteristics of the MRSA
strains that cause infection within Saudi Aramco community and to compare and contrast
the concordance/discordance of genotyping methods with the three common phenotyping
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classifications. An assessment of each phenotyping method’s validity in the identification
and management of MRSA was needed to develop a potent infection control strategy that
can address the needs of a community.
The findings of this study offer new insights into the epidemiological and
molecular factors that affect the transition of MRSA from health care facilities to Saudi
Aramco community settings. This study may make significant contributions to the
international community by in elucidating the epidemiological and molecular forces
affecting variations in MRSA disease frequency and disease severity (Chambers, 2005;
Enright et al., 2002; Oliveira, Tomasz, & deLencastre, 2002).
Background
The number of cases of multidrug-resistant Staphylococcus aureus continues to
increase, particularly MRSA, which is now a leading cause of nosocomial infection
worldwide. A nosocomial infection is defined as any infection that develops during, or as
a result of, an admission to an acute care facility (hospital) and which was not incubating
at the time of admission (Siegel et al., 2006). MRSA is responsible for up to 60% of
nosocomial infections in intensive care units (ICUs), likely due to carrying exogenous
mobile genetic elements, inadequate antibiotic therapy, and contaminated hands
(Inweregbu, Dave, & Pittard, 2005).
Treatment of MRSA infection has been challenging due to the inefficiency of first
and second line antibiotics, making the only treatment choice the use of more toxic,
expensive, and less effective antibiotics (Centers for Disease Control and Prevention
(CDC), 2013a). The CDC has reported an encouraging decrease in the rate of HA-MRSA
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in the United States with approximately 31,000 fewer cases and 9,000 fewer deaths
between 2005 and 2013 (CDC, 2013b).However, in Saudi Arabia, the MRSA prevalence
in hospitals increased from 5% in 1995 to 35% in 2013(Al Yousef, Mahmoud, & Taha,
2013).
Molecular epidemiology studies indicate that the massive geographic spread of
MRSA resulted from the dissemination of relatively few epidemic clones. Five major
lineages have been defined, which were mainly disseminated in southern and eastern
Europe, Latin America, and the United States (Oliveira et al., 2002). The five major
MRSA lineages are Iberian, Brazilian, Hungarian, New York/Japan, and pediatric
(Stefani & Varaldo, 2003). The continuing dissemination of these lineages indicates that
they are successful in terms of ability to cause infection, to persist, and to spread from
one geographic site to another, including across continents (Oliveira et al., 2002). As
mentioned earlier, the increased rate of MRSA infections outside hospital setting led to
categorization of MRSA into two distinct groups, HA-MRSA and CA-MRSA (CDC,
2005). Nevertheless, several molecular and biological parameters have been involved in
classifying MRSA.
HA- MRSA has been reported among patients with certain risk factors including
recent hospitalization, dialysis, residence in a long-term care facility, presence of invasive
devices, and history of MRSA infection and colonization (Klevens et al., 2007). HAMRSA can cause a variety of diseases from noninvasive infection such as mild
intermittent abscesses, to life threatening invasive systemic diseases such as necrotizing
pneumonia, kidney infection, joint infection, and blood stream infection. Based on their
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site of infection, HA-MRSA strains are classified into noninvasive and invasive types. In
addition, the HA-MRSA strains, in particular the invasive form, are also typically
resistant to multiple, non-beta-lactam antibiotics (Fey et al., 2003). The HA-MRSA strain
types identified by PFGE are USA100, USA200, USA600, USA700, USA800, and less
often USA500 (Klevens et al., 2007; McDougal et al., 2003). Other markers such as the
presence of SCCmec I, II, and III, agr group II, and low PVL carriage have been used to
distinguish HA-MRSA from CA-MRSA. PFGE genotyping aids in determining bacterial
isolate identification by acting as DNA “fingerprinting.” In epidemiology, genotyping
techniques can help track the spread of infections, monitor trends in types, and track
seasonal outbreaks (Healy et al., 2005). With regard to HA-MRSA infections, genotyping
techniques are excellent tools to investigate the genetic relationship between the different
HA-MRSA strains and severe infections in health care settings.
CA- MRSA has been described in patients without the established health care risk
factors. CA-MRSA was first described occurring in specific populations with distinctive
risk factors such as prisoners, intravenous drug users, athletes, military trainees, and men
who have sex with men (Kazakova et al., 2005; McCaig et al., 2006). This form of
MRSA usually presents as noninvasive infection, such as skin and soft tissue infections.
CA-MRSA isolates are likely to be resistant to fewer antibiotics, produce different toxins,
and have genetically distinct genes compared to HA-MRSA (McCaig et al., 2006).
Genetic markers such as SCCmec IV, agr group I and high PVL gene carriage have been
used to distinguish CA-MRSA from HA-MRSA (Tsuji, Rybak, Cheung, Amjad, & Kaatz
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2007). Strains most frequently isolated from MRSA infection of community origin
include PFGE USA300, USA400, USA1000, and USA1100 (Klevens et al., 2007).
Certain genetic differences have been identified in the two types of MRSA,
making HA-MRSA strains more resistant to beta lactams and other non-beta lactams
groups of antibiotics than CA-MRSA strains. These genetic differences also make CAMRSA infections more necrotic and easy to spread from person to person (Gillet et al.,
2002). Distinct epidemiological, clinical, and pharmacological characteristics are used to
classify MRSA infections as either health-care-associated (HA) or community-associated
(CA) (CDC, 2005). On the epidemiologic and clinical side, HA-MRSA strains usually
infect older, unhealthy people, whereas CA-MRSA strains have the tendency to infect
healthy, younger people and to cause distinct clinical syndromes such as soft skin tissue
infections (SSTIs) (CDC, 2005). However, an increased number of necrotizing
pneumonia and severe sepsis cases have been reported, associated with CA-MRSA
(Seybold et al., 2006). From the pharmacological side, HA-MRSA infections usually
require intravenous antibiotic therapy administered in a hospital setting, whereas CAMRSA infections respond more to ambulatory oral antibiotics. The ambulatory treatment
option reduces the length of hospitalization, lowers associated costs, and eliminates the
potential side effects of intravenous antibiotics (Doebbeling et al., 1993; Fey et al., 2003).
These epidemiological, biological, and clinical characteristics of MRSA have pushed
hospitals and other health care settings to apply a variety of phenotyping and genotyping
methods to classify MRSA infections as either HA-MRSA or CA-MRSA (CDC, 2005).
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The distinct characteristics of MRSA guided CDC and the Clinical Laboratory
Institute (CLSI) to create the three most popular phenotyping methods used currently to
differentiate MRSA as CA-MRSA or HA-MRSA. According to the health care risk
factors method, any MRSA infection identified after 48 hours of hospital admission is
labeled as HA-MRSA (CDC, 2005). According to the infection type method, any MRSA
isolated from an invasive site; blood; cerebrospinal fluid (CSF); pleural fluids from
patients who have the following risk factors: hemodialysis, surgery, residence in a longterm care facility or hospitalization during the previous year; or the presence of an
indwelling catheter or a percutaneous device at the time of culture, is labeled as HAMRSA. However, any MRSA isolated from patients who lack the above risk factors is
labeled as CA-MRSA (CDC, 2005). The last method is the susceptibility pattern method,
where MRSA cases resistant only to β-lactams antibiotics are labeled as CA-MRSA,
whereas cases resistant to additional antibiotics classes, such as carbapenems,
aminoglycoside, and fluoroquinolones, are labeled as HA-MRSA (Clinical and
Laboratory Standards Institute, 2005). Such classification is important to monitor trends
in antimicrobial resistance among MRSA within health care settings and for the selection
of appropriate antibiotics regimens. Although phenotyping methods are widely used, the
emergence of invasive and multidrug resistant CA-MRSA strains as a cause of health
care associated infection (Gillet et al., 2006; Seybold et al., 2006), and the increased
circulation of HA-MRSA in the community (Miller et al., 2007; Seybold et al., 2006)
might interfere with the sensitivity of these phenotyping methods.
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CA-MRSA has been a growing problem with increasing incidence and prevalence
in Saudi Arabia communities, and the migration of CA-MRSA into Saudi health care
settings. In the Middle East and in particular in Saudi Arabia, most of the studies
conducted between 1990 and 2008 to classify MRSA as CA-MRSA or HA-MRSA were
based on phenotyping methods, in particular susceptibility pattern method (Monecke et
al., 2012). According to Sievert (2008), only 20 % from 2151 cases in the United States
were consistently classified as HA-MRSA by the three phenotyping methods (health care
risk factor, infection type, susceptibility pattern) and 25% were consistently classified as
CA-MRSA. However, the discrepancy in the classification as CA-MRSA or HA-MRSA
exceeded 40% between the three methods. Several studies have shown that phenotyping
markers are more prone to change in time than genotyping markers (Devita, Lawrence, &
Rosenberg, 2009). Such a change is due to loss of extrachromosomal genetic elements
and later their horizontal transmission (Devita et al., 2009) and can explain the
discrepancy between the classification methods that depend on the phenotyping markers
(Tenover et al., 1994).
The revolution in genotyping methods that are based on DNA analysis has
allowed for an accurate and precise MRSA classification due to markers that are less
prone to change in time (Tenover et al., 1994). Therefore, genotyping methods have a
discriminative power for MRSA typing. A recent genotyping study in Saudi Arabia has
found that HA-MRSA resistance markers (e.g., aacA-aphD, aadD) are now common
among CA-MRSA strains (Monecke et al., 2012). Clearly, the presence of these
resistance markers in both HA and CA-MRSA will negatively affect the accuracy of the
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susceptibility pattern method and therefore its role in monitoring the emergence of the
new necrotic and invasive CA-MRSA strains. Moreover, these susceptibility methods are
essential for the proper administration of the glycopeptide Vancomycin that is routinely
used to treat HA-MRSA. However, the inappropriate and excessive usage of this
antibiotic can lead to the emergence of vancomycin-resistant Staphylococcus aureus
(VRSA) (Hiramatsu, Cui, & Kuroda, 2001).
With the advent of highly sensitive and specific PCR, genotyping methods, in
particular real time PCR, and the limitations of phenotyping methods due to the
instability of phenotyping markers, new multiplex real time PCR methods have emerged
as essential tools for studying the epidemiology of MRSA. These new genotyping
methods have the capability to accurately classify MRSA strains as CA-MRSA or HAMRSA based on their staphylococcal chromosomal cassette mec (SCCmec) and the
presence of the PVL virulence genes (Balkhy et al., 2007). CA-MRSA strains harbor the
PVL virulence genes and a novel small mobile staphylococcal cassette chromosome mec
(SCCmec) Type IV or V genetic element, which in turn harbors the methicillin resistance
(mecA) gene. The SCCmec Type IV or V can more easily be transferred to other
Staphylococcus aureus strains compared to the larger SCCmec Types I, II, and III that
usually characterize HA-MRSA strains (Zhang et al, 2005). This easy chromosomal
transfer can explain the tremendous increase in the CA-MRSA rate (Zhang et al., 2005).
Unlike the conventional PCR methods that usually target one specific gene, multiplex
real time PCR methods target several genes specific to either CA-MRSA or HA-MRSA
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(Zhang et al., 2005). Therefore, multiplex PCR methods are highly sensitive and specific,
minimizing the errors that the absence or deletion of one specific gene may produce.
During the last two decades, several genotyping studies that target different genes
were conducted in the United States and Europe to classify accurately MRSA as CAMRSA or HA-MRSA and to understand the molecular characteristics of the most
predominant strains (Monecke et al., 2012). However, the health care settings in the
Middle East, including Saudi Arabia, did not introduce the same types of genotyping
studies until 2012 (Monecke el al., 2012). Although genotyping methods that target
different genes are very sensitive and specific, they are expensive, and the majority of
health care centers in Saudi Arabia cannot afford those (Monecke et al., 2012).
Unlike methicillin-sensitive Staphylococcus aureus (MSSA) and HA-MRSA, CAMRSA is characterized by its evolutionary success, a series of events that occurred within
its genome, making the new strains more fit, transmissible, and virulent (Rolo et al.,
2012). The SCCmec IV allele that characterizes CA-MRSA is probably responsible for
such evolutionary success (Rolo et al., 2012). The high level of genetic diversity of CAMRSA strains in European and American regions and the emergence of new strains every
few years can increase the impart of the pathogenicity of CA-MRSA strains in terms of
its invasion capability and antimicrobial susceptibility, posing a real challenge to
diagnostic and infection control (Hudson et al., 2013). The results of the first genotyping
study in the central province of Saudi Arabia were surprising in terms of the high gene
diversity of MRSA strains and the high prevalence of the PVL gene that usually
characterizes CA-MRSA strains (Monecke et al., 2012). However, this first study was
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limited to only the central region and therefore cannot be generalized to all Saudi regions.
Similar population strain diversity has been found to be related to the disproportional
distribution of CA-MRSA and HA-MRSA in the United States (Klevens et al., 2007;
Rolo et al., 2012). Currently in Saudi Arabia, the selection of phenotyping method to
guide infection control strategies in Saudi health care setting depends only on the
methods validated for hospitals in the United States (Bukharie, 2010). It is essential to
enact an evaluation policy implementing phenotyping methods where applicable and to
establish new validation rules for health care settings that are planning to apply these
methods. Such policy will serve as the basis of a continuous surveillance strategy aimed
at detecting and controlling CA-MRSA in Saudi Arabia (Popovich, Hota, Rice,
Aroutcheva, & Weinstein, 2007).
Statement of the Problem
Increasing cases of HA-MRSA and CA-MRSA isolated from health care systems
and the communities require more effective methods of classification (Klevens et al.,
2007). Many investigators have classified MRSA infections into CA-MRSA and HAMRSA using approaches advocated by the CDC and the CLSI in order to guide decisions
about antibiotics empirical treatment, and to contain the spread of MRSA infection
(David et al., 2008). However, the circulation of both HA-MRSA and CA-MRSA in the
community, the emergence of CA-MRSA as a nosocomial pathogen, and the
identification of high-risk groups for MRSA in the community, including athletes,
children, and incarcerated people, raise doubt about the utility of such approaches (David
et al., 2008). The spread of multidrug resistant Staphylococcus aureus strains has made
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the infection challenging and costly to treat (CDC, 2013b). The inherent limitations in
therapeutic options necessitate implementation of infection prevention and control
procedures in an attempt to limit MRSA spread (Monecke et al., 2011). The cost of such
procedures and of the use of second-line antimicrobial medications amounts to billions of
dollars/euros in the United States and Europe (Monecke et al., 2011). Different countries
worldwide have applied different strain typing methods over the last 30 years to track
MRSA spread and provide insight into its control (Monecke et al., 2011; Stefani et al.,
2012). However, Saudi Arabia still struggles with understanding the distinction between
CA-MRSA and HA-MRSA infection types, risk factors and patients’ characteristics such
as age distribution for each strain type, seasonality, and potential shifts in therapeutic
drug resistance. Health care risk factor is currently the method most commonly used by
the infectious disease specialists at the Johns Hopkins Aramco Hospital in Saudi Arabia
to classify MRSA; however, no unified method has been adopted and classification by
phenotype remains subject to individual physicians’ perspectives. As the prevalence of
MRSA continues to increase along with its geographical diversity in colonization and
infection rates, and as the number of available therapies decrease, health care providers
should take notice of their local rates of resistance (Ezeanolue et al., 2008).
This study aimed to fill the gap in understanding in Saudi Arabia with respect to
distribution of MRSA in the community and the associated need for the development and
testing of a rapid, efficient, inexpensive, and reliable method of identification of HAMRSA and CA-MRSA strains circulating in the region.
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Purpose of the Study
The purpose of this quantitative, secondary data analysis study was to characterize
the MRSA strains within the Saudi Aramco community and to identify accurately MRSA
strains infection as HA-MRSA or CA-MRSA by comparing and contrasting the three
existing phenotyping methods against the gold standard Multiplex PCR method.
Research Questions and Hypotheses
The aim of this research study was to answer the following questions and
associated hypotheses:
1. What is the distribution of MRSA in Saudi Arabia Eastern Province based on
genotyping?
2. What is the concordance between each pair combination of three phenotyping methods
(health care risk factor, infection type, susceptibility pattern) used to classify CA- MRSA
vs HA -MRSA in Saudi Arabia?
3. What is the sensitivity and specificity of each phenotyping method (health care risk
factor, infection type, susceptibility pattern) used in Saudi Arabia as compared to the
gold-standard used to classify CA- MRSA vs HA –MRSA?
4. How well does a combination of demographic and phenotyping variables of the current
three phenotyping methods (health care risk factors, infection type, and susceptibility
pattern) predict MRSA genotyping classification as CA-MRSA or HA-MRSA?"
H0: Demographic and phenotyping variables do not significantly predict MRSA
genotyping classification.
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Ha: Demographic and phenotyping variables significantly predict MRSA
genotyping classification.
Theoretical Framework
My research study was grounded in the Ecological theory (Hardin, 1960; Kouyos,
Klein, & Grenfell, 2013). In ecology, the competitive exclusion principle, or Gause's law
of competitive exclusion, is a proposition that states, “Two species competing for the
same resources cannot co-exist if other ecological factors are constant. When one species
has even the slightest advantage or edge over another, then the one with the advantage
will dominate in the long term” (Hardin, 1960, p. 1292). Based on the Ecological theory,
coexistence of HA-MRSA and CA-MRSA would be possible in environments where
ecological factors are constant. However, either CA-MRSA or HA-MRSA would outcompete the other and predominate depending on different environmental conditions
(Hardin, 1960; Kouyos et al., 2013). HA-MRSA is classically characterized by a broad
resistance antibiotic resistance spectrum conferred by its relatively large Staphylococcal
cassette chromosome (SCCmec); SCCmec is a complex mobile genetic element found in
Staphylococcus aureus (Ito et al., 2014; Shore & Coleman, 2013). HA-MRSA usually
carries either SSCmec II or III, which have acquired genes for resistance to antibiotic
classes beyond the β-lactams (Hiramatsu et al., 2002). CA-MRSA strains tend to carry
SSCmec IV and V, which are relatively small. Thus, CA-MRSA strains tend to be
susceptible to clindamycin and other non-β-lactam antibiotics (Naimi et al., 2003). Under
ecological theory, these factors would favor HA-MRSA in a health care environment
where there is common use of antibiotics. The presence of SCCmec II or III correlates
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with slower growth than elements IV or V. Thus in the community, in the absence of
antibiotics, CA-MRSA carrying SCCmec IV or V may be at a selective advantage
(Monecke et al, 2011). However, the contribution of Fluoroquinolones' selective pressure
in the emergence of new CA-MRSA strains in the health care settings and their lower
biological cost of resistance, makes them excellent candidates to replace HA-MRSA
strains in health care settings (Kouyos et al., 2013; LeBlanc et al., 2006). The ecological
theory was thus very useful to explain the tremendous increase in CA-MRSA rate within
health care settings, and it can justify why there are misclassifications of certain strains of
CA-MRSA. Understanding genotypic virulence factors for the two will aid in formulating
critical intervention measures to reverse the current incidence trends by geographical
location.
In the application of Ecological theory, if the genotyping variables that influence
the evolution and transmission of CA-MRSA and HA-MRSA were defined as bases of
MRSA gold standard characterization methods (independent variables), and bases of
phenotyping methods validation, then accurate MRSA characterization was expected to
contribute to the regulation of MRSA acquisition, transmission, and eradication. As
shown in Figure 1, two independent variables (mecA gene, and PVL gene) influence two
dependent variables (CA-MRSA, and HA-MRSA), mediated by the influence of three
intervening variables (Health care risk factor, infection type, and susceptibility pattern).
The PVL gene and SCCmec gene influence the three phenotyping methods. For example,
the presence of PVL gene makes MRSA more invasive and therefore affects the infection
site while the SCCmec gene has direct effects on the antibiotics panel. The infection type,
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health care risk factors, and antibiotics panel that were used to phenotypically classify
MRSA are not independent of the genetic profile of the organism. The genetic profile
influenced the phenotypic characteristics and the behavior of MRSA.

17
MRSA Characterization

MRSA Characterization

Technical Outcome

Healthcare Settings

Community

Genotyping Methods base

Phenotyping Methods

(Dependent

Outcomes

Outcomes

mecA gene detection
1.

SCCmec I

2.

SCCmec II

3.

SCCmec
III

4.

SCCmec

Health care risk factor
1.

2.

MRSA acquisition

Hospitaliz
ed >48
hours

regulation
1.

Antibio
tics
steward
ship
progra

Non
Hospitalized
Proper MRSA

.MRSA eradication
1.

Decontaminatio
n

2.

Health
education

Characterization
PVL gene detection

Infection type
1.

2.

1.
Invasive
infection
Superficial
infection

2.

CAMR
SA
HAMRSA
MRSA transmission
regulation

Susceptibility pattern
1.

1.

Isolati
on and
contact
precaut
ion

2.

Infecti

Aminogly
cosides

Figure 1. Conceptual framework for the independent, dependent variables, and the expected outcomes of the study.
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Nature of the Study
This study was a quantitative, secondary data analysis aimed at describing the
current performance of three phenotyping methods used to classify MRSA strains. First, I
classifed MRSA cases as either HA-MRSA or CA-MRSA based on the threephenotyping methods. Then, I measured the concordance of each pair combination of
phenotypic methods. Finally, I described each method’s accuracy based on their
sensitivity and specificity against a reference genotyping method (Multiplex PCR) as the
gold standard and then determined the effectiveness of a predictive model using
Goodness-of-Fit statistics. Multiplex PCR is characterized by its high sensitivity,
specificity, positive predictive value (PPV), and negative predictive value (NPV)
(Kimura et al., 2009). In this study, molecular phenotypes of the MRSA strains causing
infection within the Saudi Aramco community in the Eastern province of Saudi Arabia
were analyzed and compared to the genotypic information generated for the collected
samples. It was the second such study in Saudi Arabia, since a study conducted in 2012 in
the central province to accurately classify MRSA strains as CA-MRSA or HA-MRSA
based on their staphylococcal chromosomal cassette mec (SCCmec) and their PVL genes
simultaneously (Monecke et al., 2012). Besides the molecular characteristics of the
MRSA strains, I assessed the utility of the current phenotyping methods in infection
control and treatment management program by measuring concordance. A poor
concordance supported the necessity of a full assessment of each phenotyping method
separately through the measurement of its sensitivity and specificity against the
genotyping gold standard method (Multiplex PCR) to assess its accuracy, and therefore,
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its validity. A phenotyping method with good sensitivity and specificity emerged as a
valid method in infection control management that primarily lack epidemiological studies
about MRSA diversity in all the regions of Saudi Arabia (El-Mahdy, El-Ahmady, &
Goering, 2013; Monecke et al., 2012). In addition, it will provide a simple, less
expensive, accurate, and feasible method for full MRSA assessment in Saudi Arabia.
For this study, I obtained the phenotypic characteristics of MRSA samples
(admission profile, infection type, and susceptibility pattern) from 133 samples collected
between January 2012 and December 2013, and stored within the John Hopkins Aramco
Health Center epidemiology and microbiology database. During the period between
January 2012 and December 2013, this center started collecting all MRSA samples in
order to test the new multiplex PCR system. All isolated MRSA samples were analyzed
for PVL gene and SCCmec gene to classify MRSA as CA-MRSA or HA-MRSA using
new technology. However, no comparison between phenotyping methods and this new
genotyping method had been conducted to date; this was the aim of this study. SAP
health care system (SHC) within John Hopkins Aramco Health Center and the Molecular
biology and Microbiology sections in John Hopkins Aramco Health Center were the
source of demographic information (Age, gender, and survival), medical history of
involved patients, and genotyping characteristics, respectively.
Definition of Key Terms
The key terms included are used predominantly by medical and public health
sectors and are terms that may require definition in order to be useful to the reader. The
key terms used in the study were:
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Aminoglycosides: “Antibiotics containing two or more amino sugars in glycoside
linkage with a hexose nucleus, which are bactericidal” (Spencer, 1986, p. 216)
Beta-lactam antibiotics: Class of antibiotics with a beta-lactam ring structure that
inhibits bacterial growth by altering the synthesis of the cell wall. These antibiotics
include penicillins, extended-spectrum penicillins, cephalosporins, imipenem, and
aztrenonam (Meriam-Webster, 2013).
Biological cost of resistance: a reduction in bacterial fitness that can be expressed
as lower growth, and altered virulence or transmission (Meriam-Webster, 2013).
Fluoroquinolone: Class of antibiotics of fluorinated derivatives (Meriam-Webster,
2013).
Infectivity: Ability to produce infection; tendency to spread rapidly from host to
host (Meriam-Webster, 2013).
Polymerase chain reaction (PCR): a genotyping technique based on synthesizing
large quantities of well-defined DNA segment (Meriam-Webster, 2013).
Pulsed-field gel electrophoresis (PFGE): molecular typing method based on the
separation of chromosomal DNA molecules after applying an electric field that change
their directions (Meriam-Webster, 2013).
Scope and Delimitations
The study scope was to investigate the validity of the three phenotyping methods
that are currently used to classify MRSA as CA-MRSA or HA-MRSA within John
Hopkins Aramco Health Center in the eastern province of Saudi Arabia. Based on the
disproportional distribution of CA-MRSA and HA-MRSA between countries and
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populations (Klevens et al., 2007; Rolo et al., 2012) and the emerging of new CA-MRSA
strains (Akoglu et al., 2007), I assumed that the Saudi population had distinct MRSA
phenotype and genotype that need to be explored in a specific manner.
This research study was delimited to patients at the John Hopkins Aramco hospital in the
Eastern Province, Saudi Arabia. The population for this health center consists of
approximately 350,000 employees, dependents or annuitants of the Saudi Aramco energy
corporation. The study was further delimited to data and samples collected from January
2012 and December 2013.
Assumptions
Assumptions for this research were that the phenotypic and genotyping
characteristics data generated for the MRSA samples for the same strains were
comprehensive and representative of the distribution across the population under study. I
also assumed that the data stored at the John Hopkins Aramco Health Centre of Saudi
Arabia had phenotypic and genotypic characteristics distinct from those observed in other
countries, consistent with the genetic diversity existing in MRSA strains isolated from
different populations (Hudson et al., 2013).
Limitations
Patients’ electronic medical records (EMR) were the only source of data. I did not
conduct patients’ interviews; therefore, information on preexisting health conditions and
health care risk factors were not available for some patients due to the recent
implementation of the electronic health care information system. However, I attempted to
access paper medical records to help minimize missing data after receiving approval from
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the infection control department. From the geographical and temporal perspectives, the
molecular characteristics of MRSA that are evolving are moving targets. Evolutionary
success is an important characteristic of CA-MRSA strains that makes their growth rates
1.33 faster than HA-MRSA strains (D’Agata, Webb, Horn, Moellering, & Ruan, 2009).
Therefore, current strains may differ from strains that were analyzed two years before,
making the ratio of CA-MRSA to HA-MRSA strains of the year 2012 and 2013 not fully
representative for 2014 and 2015. Although, heterogeneity of strains does not have had a
significant impact on the genotyping methods, which are based on DNA analysis, it does
affect phenotyping methods. The phenotyping methods are based on the organism’s
physical traits that can be altered by the evolution of new CA-MRSA strains (D'Agata et
al., 2009). A comparison between phenotyping methods and genotyping methods
minimized the impact of these limitations. The migration of CA-MRSA genes such as
PVL gene into HA-MRSA strains makes the physical traits of HA-MRSA similar to CAMRSA. Thus, the SCCmec gene was included in the genotyping profile to increase
accuracy in classification and minimize the impact of this evolution.
Significance of the Research
MRSA is a serious pathogen associated with various severe infections that affect a
significant proportion of the world population (CDC, 2013a). However, the greatest cause
for concern is the resistant nature of the bacterium (CDC, 2013a). MRSA drug resistance
is a serious issue as it may threaten the safety of the world population by increasing
morbidity and mortality rates associated with Staphylococcus aureus infections (CDC,
2013b). In addition, the resistant nature of the infections has significant cost implications,
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related to the treatment and management of the patients, as well as prevention and control
measures. (Boyce, Landry, Deetz & DuPont, 1981; Monecke et al., 2011; Stefani et al.,
2012).
MRSA infections are more severe when compared with methicillin-susceptible
Staphylococcus aureus. Severe MRSA infections may require specialized medications
and treatments including isolation, ventilation, hyperbaric therapy, and surgical
debridement (Klevens et al., 2007). The severity of resistant infections reduces the
available antibiotic options, which results in additional risk to the patient due to treatment
toxicity and lengthy hospitalization (Lodise & McKinnon, 2005). In some cases,
medications and treatments are ineffective and result in morbidity or mortality (Lodise &
McKinnon, 2005).
MRSA hospitalization cost is nearly double than that for non-MRSA infections
(Elixhauser & Steiner, 2007). Thus, the screening of MRSA to identify strains is
important in the prevention of disease transmission and the conservation of hospital
resources. Understanding the dynamics of MRSA infection may assist physicians in
selecting appropriate treatment, identifying interventions, and preventing transmission in
the population. Better tracking of MRSA strains nationwide is necessary to observe and
control their spread.
Presently, the management of MRSA infections worldwide has become a priority
in health care settings. Susceptibly pattern, patients’ age distribution for each strain type,
and seasonal pattern of CA-MRSA and HA-MRSA infection are important factors in the
management of MRSA infections. CA-MRSA, which is less resistant to non-beta-lactams
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antibiotics, has a tendency to infect younger people in the summer months while HAMRSA, which is also resistant to non-beta-lactams antibiotics has a tendency to infect
older people in the winter months (Klein et al., 2007). Most initiatives in MRSA
management target reduction of the spread of MRSA in order to relieve the burden of
high medical costs and reverse the trend of MRSA morbidity and mortality.
At the molecular level, the role of genetic markers is important in mapping the
Saudi Aramco population who may be at high-risk for MRSA infections. Genetic
markers increase the accuracy of diagnoses needed to determine appropriate treatments
(Healy et al., 2005). Such accuracy is essential for an effective treatment model, feasible
and appropriate infection control strategies, and targeted prevention efforts for these
emerging strains. My results contributed to the existing body of knowledge about health
care settings and environmental factors that contribute to the predominance of CAMRSA or HA-MRSA infection in Saudi Arabia. The results of this study offered insights
about MRSA and the Saudi Aramco populations that are at higher risk for subsequent
MRSA infection. Further, the results of this study will ultimately help in the formulation
of prevention strategies to reduce MRSA transmission, such as disease surveillance, and
raise awareness of the scope of the problem. The potential for positive social change,
associated with my study results, lay in its aim to demonstrate the differences between
CA-MRSA and HA-MRSA infections types, patients’ age distribution for each strain
type, the seasonality of MRSA infections, and any potential shifts in therapeutic drug
resistance and identification of phenotyping variables that can be applied to distinguish
between HA-MRSA and CA-MRSA and hence gauge distribution for each MRSA type,
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seasonality, and potential shifts in therapeutic drug resistance. Patients will benefit from
an increased understanding of the disease and identification of potential treatment
modalities related to each strain. Non-infected individuals will benefit from a better
understanding of the source of the strains and the resultant policies aimed at controlling
the spread of MRSA. Thus my study contributed to positive social change among the
Saudi Aramco population, as better management of existing MRSA will reduce incidence
of the infection as well as the morbidity and mortality often associated with MRSA
strains. A reliable and affordable MRSA screening program based on concordance of
phenotyping classification with a genotyping gold standard provides a rational basis for
MRSA surveillance and characterization. Extending the findings of this study to other
health care facilities throughout the country would potentially contribute to the
development of such a screening program.
Potential strategies towards positive social change deriving from this research are
the development of a MRSA screening program, and the education of health workers.
The results of the study will help increase understanding of MRSA outbreaks through
comparative analysis of data from previous studies worldwide. Findings from
comparative analyses will advance knowledge on the diseases' genetic, epidemiological,
and clinical characteristics.
Summary
MRSA infections can range from mild to life-threatening in human beings
(Monecke et al., 2011; Stefani et al., 2012). The risk factors of HA-MRSA are well
known, but the increase in CA-MRSA and the movement of CA-MRSA to health care
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settings has changed the epidemiology of the disease. More research is necessary to
elucidate the burden and impact of MRSA, in particular invasive MRSA, on communities
as well as health care settings. In order to describe and target interventions among
populations at risk, several infection control measures are necessary including an
antimicrobial stewardship program and an increased understanding the epidemiology of
MRSA in specific population. Poor assessment of CA-MRSA and HA-MRSA prevalence
within a facility can lead to the administration of unnecessary and/or improper
antibiotics, causing a selective pressure on the factors that are responsible for the high
rate of multidrug resistance strains (MDR) in Saudi Arabia. Hence, my study was
conducted within the Saudi Aramco community in the Eastern province of Saudi Arabia.
It was the first study conducted to obtain data to assess the molecular characteristics of
the MRSA strains causing infection in this population.
Molecular methods such as genotyping are involved in classifying MRSA
infections and identifying MRSA strains to arrive at preventive and control measures. In
the absence of molecular methods, three phenotyping methods have been used to
differentiate the strains. The purpose of this study was to identify a non-arbitrary,
verifiable combination of phenotyping variables to allow reliable classification of MRSA
in the Saudi Aramco region of Saudi Arabia into HA-MRSA or CA-MRSA.
The underlying reason for carrying out the study was that this enhanced
understanding would help to establish a feasible and effective screening and treatment
program. An accurate and less expensive phenotypic method would help the infection
control department to monitor and investigate the prevalence of CA-MRSA and HA-
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MRSA infections more precisely. The absence of a standardized phenotyping method for
assessing MRSA is a real challenge for the infection control program in Saudi Arabia.
Chapter 1 illustrated the gaps in the research this study sought to fill, the purpose
and nature of the endeavor relative to the entire body of research, the research questions
and hypotheses, the theoretical basis that provided a framework for the study, and an
organizing model for the research questions. It also discussed the significance and social
change implications this study may have relative to the research topic. This approach
allowed more effective establishment of epidemiology of MRSA in the region, in order to
help with surveillance and prediction/control of epidemic outbreaks, and allow
appropriate antibiotic treatment regimens to be applied in a timely manner.
In Chapter 2, I provide an overview of the current literature on MRSA in Saudi
Arabia, Middle East, Europe, and the United States. The chapter briefly outlines the
emergence of MRSA bacteria; considers the impact of the infection on populations from
a cost, morbidity, and mortality standpoint; and identifies what current research is
available regarding the epidemiology of MRSA. The chapter includes a general
discussion on the traditional methods for defining CA-MRSA disease and the clinical and
molecular epidemiology of CA-MRSA disease.
Chapter 3 details the methodology I used while completing my research. The
study design, data sources, abstraction instruments, and details of my analyses are
discussed.
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In chapter 4, I present the results of my analyses. I utilized John Hopkins Health
Care Center MRSA infection data, and MRSA multiplex PCR classification data to
conduct the statistical analyses used to answer the research questions in detail.
In chapter 5, I summarize, interpret and discuss key research findings. In addition,
I include recommendations for the application of the study findings and future research.
Finally, I discuss the impact of my study results and its potential implications for positive
social change.
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Chapter 2: Literature Review
CA-MRSA and HA-MRSA strains have spread into health care settings in Saudi
Arabia, bringing increased morbidity, mortality, and financial burdens (Bukharie, 2010).
Unfortunately, current prevention controls in Saudi Arabia rely on MRSA phenotyping
methods imported from other countries without testing validity or effectiveness of those
methods (Bukharie, 2010). This approach to MRSA typing poses additional health care
concerns when attempting to treat the MRSA strains effectively.
International consistency lacks in typing and naming MRSA strains, and
uncertainty regarding what constitutes CA-MRSA is prevalent. In Saudi Arabia, there is a
lack of studies on locally relevant strains. Currently, there is no MRSA national control
program in Saudi Arabia despite increased prevalence of MRSA (Baddour et al., 2007;
Bukharie, 2010). This dearth of information is highlighted by the limited number of
reports identified by the National Library of Medicine of MRSA infections in Saudi
Arabia when compared with other countries such as the United Kingdom or the United
States (Baddour et al., 2007). A classification scheme for Saudi Arabia, appropriate for
use at local, regional, and national levels, is needed to harmonize surveillance and
treatment programs, in keeping with recommended best practice (Stefani et al., 2012).
This need was the context for the research problem I addressed in this study.
In this review, I provide an overview of the literature review search strategy, as
well as review of the theoretical framework, and the current literature on risk factors,
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epidemiology, and genetics for both HA-MRSA and CA-MRSA. I critically analyzed
published studies on different genotypic and phenotypic methods used for classification.
Literature Search Strategy
Though I reviewed literature dating back to 1950 to explain the emergence of
MRSA, I placed emphasis on including a substantial number of peer-reviewed
publications in acceptably high-impact journals from the last 5 years. I also consulted
reports and websites of reputable bodies including the CDC.
I used the PROQUEST database and the PubMed search engine to identify the
extant literature. Relevant electronic databases were accessed including Medline, Science
Direct, and the Institute of Scientific Information (ISI) Web of Knowledge citation
indexes. I used various keywords and phrases at different times in compiling sources for
the literature review. I remained aware of issues such as the existence of synonyms for
the search terms, as well as plurals, alternative spellings (e.g., U.S. versus U.K. English),
and alternative and related terms. Having identified keywords, I used them singly or
combined as search terms with Boolean operators AND, NOT, and OR. Truncation was
often used in searches account for spelling variations, plural versus singular, and root
words, commonly by using an asterisk or a question mark to replace a single letter or a
string of letters. Keywords searched either singly or in various combinations included
Staphylococcus aureus; Methicillin Resistant Staphylococcus aureus (MRSA); community
associated or community-acquired or community onset; CA-MRSA; HA-MRSA;
nosocomial, strain*; clonal complex*; phenotype; phenotyping classification; method;
genotype; genotyping classification; concordance; antibiotic*; methicillin; vancomycin;
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susceptibility; resistance; antibiogram; health care; risk factor* and appropriate articles
with a specific reference to Saudi Arabia. Moreover, I also sought and scrutinized
distinctive antibacterials through PubMed. Various other articles, which were procured
from the reference section of source articles, were acquired through PubMed.
Theoretical Foundation
The ecological theory and antibiotics selection pressure (ASP) theory supported
this study. In ecological theory, the competitive exclusion principle or Gause’s law of
competitive exclusion states that “two species competing for the same resources cannot
coexist if other ecological factors are constant. When one species has even the slightest
advantage or edge over another, then the one with the advantage will dominate in the
long term” (Hardin, 1960, p. 1292). Ecological theory thus dictates that both coexistence
and competition can occur between CA-MRSA and HA-MRSA (Kouyos et al., 2013).
HA-MRSA is classically characterized by a broad resistance antibiotic resistance
spectrum conferred by its relatively large Staphylococcal cassette chromosome
(SCCmec); SCCmec is a complex mobile genetic element found in Staphylococcal
aureus (Ito et al., 2014; Shore & Coleman, 2013). In MRSA, it carries the PBP2aencoding mecA gene responsible for the β-lactam antibiotic resistance, that is absent in
resistant MSSA strains (Hiramatsu et al., 2001). HA-MRSA usually carries either
SSCmec II or III, which have acquired genes for resistance to antibiotic classes beyond
the β-lactams (Hiramatsu et al., 2002). CA-MRSA, in contrast, tends to carry SSCmec IV
and V, which are relatively small. Thus CA-MRSA strains tend to be susceptible to
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clindamycin and other non-β-lactam antibiotics (Naimi et al., 2003). Under ecological
theory, therefore, these factors would favor HA-MRSA in a health care environment
where there is common use of antibiotics. Conversely, the presence of SCCmec II or III
correlates with slower growth than elements IV or V. Thus in the community, in the
absence of antibiotics, CA-MRSA carrying SCCmec IV or V may be at a selective
advantage. This was proposed to explain why CA-MRSA out-competes HA-MRSA in
the community (Monecke et al, 2011). The classification of HA-MRSA and CA-MRSA
has been challenged by studies suggesting that MRSA isolates characterized as
containing SCCmec IV and PVL, and. thus genotypically CA-MRSA are emerging in the
health care environment (David et al, 2008a). CA-MRSA strains are characterized by a
lower biological cost of resistance, making them viable candidates to replace HA-MRSA
strains in health care settings (Kouyos et al., 2013). The ecological theory is thus useful
in explaining the increase in CA-MRSA rates within healthc are settings, and in particular
the emerging multidrug resistant CA-MRSA. This theory can also be used to explain why
certain strains of CA-MRSA are misclassified as HA-MRSA.
According to ASP theory, there is a link between increasing use of
fluoroquinolones antibiotics and the emergence of new CA-MRSA strains (LeBlanc et al,
2006). This supports the importance of establishing a correlation between commonly
prescribed antibiotics and the occurrence of CA-MRSA infection. The theory of ASP is
also very useful to explain why some CA-MRSA strains are becoming resistant to
different groups of antibiotics, which might interfere with the susceptibility pattern
classification of MRSA.
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For this study, I focused on the potential CA-MRSA and HA-MRSA strains that
could spread into health care settings in Saudi Arabia, specifically in the Saudi Aramco
region of Saudi Arabia. Therefore, the study aligned with both the Ecological and ASP
theory frameworks, as both of these theories helped explain patterns of CA-MRSA or
HA-MRSA incidence and prevalence in the health care setting versus the community.
Studies to date in Saudi Arabia, suggest the prevalence of CA-MRSA is increasing and
the lines between ‘HA-MRSA’ and ‘CA-MRSA’ are blurring in terms of health care risk
factors (Al‐Tawfiq, 2006; Baddour et al., 2007; Bukharie, 2010; David et al., 2008;
Monecke et al; 2102; Moussa & Shibl, 2009; Stefani et al, 2012). The goal of this study
was to identify accurate and reliable phenotyping methods to classify MRSA into HAMRSA and CA-MRSA in concordance with a genotyping gold standard. Previous studies
on phenotyping and genotyping concordance suggested that antibiotic susceptibility
patterns (Clinical Laboratory Standards Institute (Clinical and Laboratory Standards
Institute, 2005) may be particularly helpful in classification, given the increasingly
questioned predictability of health care risk factors (Campanile et al., 2011; David et al,
2008a; Donnio et al, 2004; Hetem et al., 2012; Maree et al., 2007; Nair et al., 2011; Otter
& French, 2011; Song et al., 2011). This study therefore used the existing Ecological and
ASP theories as a suitable framework, but I was mindful of the plasticity of the
definitions of what constitutes true HA-MRSA or CA-MRSA.
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Literature Review MRSA
Classification
Staphylococcus aureus are Gram-positive cocci that colonize 20% to 30% of the
human population (van Belkum et al., 2009) as well as many animal species including
livestock and domestic animals (Lindsay 2014; Peton & Le Loir, 2014). It grows either
singly, in pairs, or in irregular clusters. Staphylococcus aureus is often carried
asymptomatically as a commensal organism. However, as a human pathogen it is
opportunistic and causes infections ranging from mild skin and soft tissue infections to
life- threatening sepsis, pneumonia, and toxic shock syndrome (TSS). The
pathophysiology depends on the presence of virulence factors including those present on
the cell surface or secreted factors.
MRSA refers to a strain of Staphylococcus aureus that is resistant to the antibiotic
methicillin. Methicillin and oxacillin resistance are due to the presence of a modified
penicillin binding protein (PBP2’, or PBP2a), which is encoded by the mecA gene (Lim
& Strynadka, 2002). This gene is found on complex mobile genetic elements called
staphylococcal cassette chromosomes (SCCmec). In practice, PBP2a confers resistance to
all β-lactam antibiotics (Fey et al., 2003), apart from ceftobiprole, including
cephalosporins, penicillin derivatives such as ampicillin, amoxicillin, ticarcillin and
piperacillin, and carbapenems (National Committee for Clinical Laboratory Standards
(NCCLS), 1997). SCC mec also variably contains genes encoding resistance to
aminoglycosides or macrolides (Ito et al., 2001; Oliveira, Wu & de Lencastre, 2000).
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This high spectrum of antimicrobial resistance complicates treatment options (Wertheim
et al., 2005).
Historical Overview of MRSA Emergence
In the 1940s, the major antibiotic available to treat Staphylococcus aureus
infections was the then newly discovered penicillin (Chambers, 2001). However by 1944
the first penicillin–resistant strain of Staphylococcus aureus had already been observed
(Chambers, 2001). The prevalence of penicillin-resistant strains began to increase,
prompting the development of new semi-synthetic penicillinase-resistant penicillins
including methicillin and oxacillin (Lodise & McKinnon, 2005). By 1961, a new
Staphylococcus aureus strain, which was resistant to methicillin, termed MRSA, had
emerged and was observed in the UK (Jevons, 1961). MRSA subsequently spread
throughout the world, although it was mainly observed as a hospital-acquired infection
(Stewart & Holt, 1963). The first reports of MRSA acquired in the community outside of
hospitals and health care facilities were in the 1980s (Levine, Cushing, Jui, & Brown,
1982; Saravolatz, Markowitz, Arking, Pohlod, & Fisher, 1982). However, until the late
1990s such reports remained infrequent. Since then, there has been a steady increase in
reports of MRSA isolated from people in the community without recent treatment in a
hospital or health care facility (Groom et al., 2001; Herold et al., 1998; Kaplan et al.,
2005; Ladhani & Garbash, 2005; Marcinak & Frank, 2003; Naimi et al., 2003; Zaoutis et
al., 2006). Whereas at first it was suspected that this marked the spread of HA-MRSA
from hospitals into the community, it became clear that in terms of antibiotic
susceptibility, epidemiology and genetics, these community associated (CA)-MRSA
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strains differed in important respects from HA-MRSA and in fact represented new strains
that had arisen in the community (David et al. 2008a).
Epidemiology and Risk Factors of HA-MRSA and CA-MRSA
HA-MRSA and CA-MRSA can be distinguished by their differing epidemiology
and risk factors. The CDC defines CA-MRSA based on the hosts' lack of health care risk
factors; in the presence of such risk factors the CDC advocates classification as HAMRSA. MRSA is a common cause of hospitalized infections. Risk factors for HA-MRSA
include surgery, hemodialysis, peritoneal dialysis, hospitalization, residency in a longterm care facility within the last year, or presence of indwelling percutaneous devices or
catheters at the time of diagnosis or previous isolation of MRSA (CDC 2005). By the
CDC definition, CA-MRSA is diagnosed when MRSA is observed in an outpatient or
within 48 hours of hospitalization, yet lacks the risk factors outlined for HA-MRSA
(Naimi et al., 2003). The rapid and accurate identification of oxacillin-resistance in
susceptibility tests (methicillin is no longer in use) is needed to determine appropriate
antimicrobial therapy (Louie et al., 2001; Pantosti & Venditti, 2009). Studies on
phenotype, genetics, and antibiotic susceptibility of MRSA suggest that the CDC
definition of CA-MRSA may be too conservative (David et al., 2008a, 2008b).
Currently, up to 85% of MRSA infections would be classified as HA-MRSA
(CDC, 2005). HA-MRSA infection refers to patients isolated after 48-72 hours of
admission to a hospital, those present at time of admission or health care workers of longterm care facilities (CDC, 2005). Patients tend to be elderly, although pre-term babies are
also susceptible (Cooke & Brown, 2010; Millar et al., 2007). Immunocompromised
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patients are susceptible to HA-MRSA (Giamarellos-Bourboulis et al., 2009), as are
patients with chronic diseases such as diabetes with skin ulcers, dialysis patients, and
people working in health care settings who have poor hygiene (Cooke & Brown, 2010;
Millar et al., 2007). HA-MRSA patients may develop pneumonia or serious invasive
infections at surgical sites and wounds, and within the urinary tract and bloodstream
(Gould et al., 2011). HA-MRSA can also become epidemic MRSA (EMRSA) and spread
between hospitals when colonized patients or staff members move from one hospital to
another. CDC guidelines suggest that transmission of HA-MRSA could be reduced by
practices such as adequate hand hygiene among medical staff, use of protective clothing
and equipment, and use of antimicrobial soap and ointment on all intensive-care unit
(ICU) patients (CDC, 2005).
The epidemiology of CA-MRSA differs from that of HA-MRSA, as the CDC
exclusionary definition implies. Infections often occur among previously healthy,
younger individuals either in an outpatient setting or within 48 hours of admission to a
health care facility (Cooke & Brown, 2010; Naimi et al., 2003). However, recent studies
suggest that these kinds of distinctions may be too limiting as strains of MRSA, which
would be genotypically CA-MRSA, also arise within health care settings (David et al.,
2008a). CA-MRSA was first observed in the 1980s when it was noted as the cause of a
sharp increase in infection among North American intravenous drug users (Minnesota
Department of Health, 2004). Later outbreaks were recognized in separate community
populations (Table 1) such as children attending day-care centers, soldiers, male
homosexuals, Native Americans, athletes in close contact sports, prisoners, and again
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intravenous drug users (Cooke et al., 2010; Cooke & Brown, 2010; Davis et al., 2007;
Diep et al., 2008a; Hidron et al., 2009; Huang et al., 2008; Thomas et al., 2007).
Table 1
Groups Experiencing Outbreaks of CA-MRSA with Risk Factors
Population or group

Possible risk factors

References- examples

Inmates/prisoners

Crowded living conditions,

MMWR, 2001; Pan et al.,

close contact

2003

Men who have sex with men

Close contact

Diep et al., 2008a

Athletes

Close contact, skin

Begier et al., 2004;

abrasions, sharing of

Kazakova et al., 2005

equipment
Military recruits

Crowded living conditions,

Ellis et al., 2004

skin abrasions
Native Americans

Close contact, crowded

Groom et al., 2001

living conditions
Children (especially in day

Close contact, skin

Herold et al., 1998; Kaplan

care centres)

abrasions

et al., 2005

Intravenous drug users

Poor skin hygiene, sharing

Cooke et al., 2010

needles
Impoverished adults (inner

Close contact, crowded

city areas)

living conditions, poor

Charlebois et al., 2002

hygiene
Risk factors for development of CA-MRSA include crowded living conditions
and poor hygiene, breaks in the skin, and skin-to-skin contact. Infections associated with
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CA-MRSA also tend to be less serious, for example skin and soft tissue infections
(SSTI), sometimes initially mistaken for an arachnid bite, which can often be treated by
excision and drainage rather than antibiotic treatment. However, these conditions can be
chronic or recurrent. Moreover, CA-MRSA is also associated with an expression of
toxins and if left untreated can lead to serious conditions such as necrotizing pneumonia,
sepsis, and osteomyelitis (Lina et al., 1999).
Genetics of HA-MRSA and CA-MRSA
HA-MRSA and CA-MRSA differ at the molecular genetic level. One major
difference is in the Staphylococcal cassette chromosome (SCCmec) expressed. SCCmec
is a complex mobile genetic element found in Staphylococcus aureus (Ito et al., 2014;
Shore & Coleman, 2013). In MRSA it carries the PBP2a-encoding mecA gene
responsible for the β-lactam antibiotic resistance, which is absent in resistant methicillinsensitive Staphylococcus aureus (MSSA) strains (Hiramatsu et al., 2001). There are
currently eleven known SCCmec types for which there are complete nucleotide sequence
data available, ranging in size from 20 to 60 kb (Garcia-Alvarez et al., 2011; International
Working Group on the Classification of Staphylococcal Cassette Chromosome Elements
(IWG-SCC), 2009; Li et al., 2011; Shore et al., 2011; Shore & Coleman, 2013). Each has
been assigned a unique Roman numeral, reflecting the order in which it was identified
(IWG-SCC, 2009). HA-MRSA is generally associated with expression of SCCmec types
I, II or III while CA-MRSA is generally associated with types IV and V. In practice, most
MRSA strains are either SCCmec II or IV (IWG-SCC, 2009; Shore & Coleman, 2013).
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Another molecular distinction between HA-MRSA and CA-MRSA is the
presence or absence of the bi-component toxin PVL (Kaneko & Kamio, 2004) which is
harbored by some CA-MRSA strains but not by HA-MRSA (Otto, 2013). Cases of CAMRSA positive for PVL have been reported worldwide (Monecke et al., 2007).
Epidemiologically, PVL expression in MRSA can be approximately divided into three
groupings (Monecke et al., 2011). In Europe, the prevalence of PVL-expressing MRSA
remains low and its expression in individuals may reflect international travel in and out of
European countries. In Australia and Abu Dhabi, prevalence of PVL-expressing MRSA
is high and may be the result of mass immigration into these countries by people from all
over the world. Finally in the USA, one PVL- expressing MRSA strain, termed USA 300,
predominates over all other strains, whether PVL expressing or not.
Although PVL was identified in Staphylococcus aureus back in 1932 (Panton &
Valentine, 1932), its presence in MRSA is relatively new (CDC, 1999). PVL is a twocomponent leukocidin toxin that acts by forming pores in the mitochondria (Genestier et
al., 2005). PVL subunit expression is considered to contribute to increased virulence in
CA-MRSA although there have been conflicting results in animal models in this regard
(Otto 2013; Lo & Wang, 2011). However, these PVL-expressing strains have been
associated with necrotizing pneumonia in previously healthy young people (Gillet et al.,
2007; Labandeira-Rey et al., 2007; Lina et al., 1999).
Genetic Elements of MRSA
SCCmec elements have various well-defined features (Ito et al., 2001, 2014;
IWG-SCC, 2009; Shore & Coleman, 2013). They integrate into the Staphylococcus
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aureus chromosome at the integration site attB within its integration site sequence (ISS),
which lies within the 3’ end of the orfX gene (Boundy et al., 2013; Ito et al., 2014); this is
exploited in some genotyping strategies. SCCmec elements are flanked by repeat
sequences and they include a cassette chromosome recombinase (ccr) and mec gene
complex. The ccr genes encode the recombinases that facilitate site- and orientationspecific SCCmec excision or integration. It is partially this capacity for mobile genetic
element transfer and re-integration that helps the spread of antibiotic resistance among
strains.
Notably, in the context of MRSA, the SSCmec also includes the mec region that
harbours, where present, the mecA gene and various mec regulatory genes including
mecI and mecR1 (Hao et al., 2012; Lim and Strynadka, 2002; Shore & Coleman, 2013).
There are currently five known mec classes and eight known ccr classes (Ito et al., 2014).
Any regions other than ccr or mec in SCCmec are designated as "joining regions" (Jregions), for which there are three known subgroups, J1-3 (Ito et al., 2014). In terms of
the multiple antibiotic resistance profile observed particularly for HA-MRSA, SCCmec
also frequently contains integrated insertions, for example plasmids or transposons from
other resistant organisms, carrying genes for resistance to other antimicrobial agents such
as aminoglycosides or macrolides (Ito et al., 2001; Oliveira, Wu & de Lencastre, 2000).
Although mecA is the gene commonly associated with conferring methicillin
resistance, the identification of a novel mecA homologue, now termed mecC, has
complicated this association recently (Paterson, Harrison & Holmes, 2013). MecC was
originally identified in an epidemiological study of bovine mastitis resulting in the
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isolation of a Staphylococcus aureus isolate called LGA251, from a bulk tank milk
sample in southwest England (Garcia-Alvarez, Webb, & Holmes, 2011). This was
phenotypically MRSA but genotyping revealed the absence of mecA.
Subsequent genome sequencing of LGA251 showed that the strain carried a novel
mecA homologue initially termed mecALGA251 which was 69% identical to
conventional mecA at the DNA level. The strain encoded a modified PBP2a/2′ that was
∼63% identical to mecA-encoded PBP2a/2’ at the amino acid level (Garcia-Alvarez et
al., 2011). This homologue has since been renamed mecC and has been identified in
human strains in reports from the UK, Denmark, Belgium and Ireland (Deplano,
Vandendriessche, Nonhoff, & Denis, 2014; Garcia-Alvarez et al., 2011; Shore et al.,
2011; Tsubakishita, Kuwahara-Arai, Baba, & Hiramatsu, 2010 ).
SCCmec elements in HA-MRSA versus CA-MRSA. Of the eleven known
SSCmec elements, HA-MRSA is generally associated with expression of SCCmec types
II or III while CA-MRSA is generally associated with types IV and V. In practice, most
MRSA strains are either SCCmec II or IV (IWG-SCC, 2009; Shore, & Coleman, 2013).
SSCmec II and III are relatively large and, as mentioned above, contain genes for
resistance to antibiotic classes beyond the β-lactams (Hiramatsu et al., 2002). SSCmec IV
and V, in contrast, are relatively small and the CA-MRSA strains that carry them tend to
be susceptible to clindamycin and other non-β-lactam antibiotics (Naimi et al., 2003).
The antibiotic-resistance profiles of CA-MRSA and HA-MRSA are therefore dictated
mainly by the SCCmec element.
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The presence of SCCmec II or III correlates with slower growth than elements IV
or V. It is postulated that in the health care environment, SCCmec II or III confers an
advantage due to the multi-antibiotic resistance profile. However in the community, in
the absence of antibiotics, SCCmec II or III-containing HA-MRSA may be at a selective
disadvantage due to its slower growth. This is proposed to explain why CA-MRSA outcompetes HA-MRSA in the community (Monecke et al, 2011). The classification of
‘HA-MRSA’ and ‘CA-MRSA’ meanwhile has been challenged by studies showing that
MRSA isolates characterized as containing SCCmec IV and PVL, thus genotypically
‘CA-MRSA’, are arising in the health care environment (David et al, 2008a).
Virulence-associated genetic factors. The key to the success of MRSA lies not
only in its antibiotic resistance profile but also in its virulence factors. Important
virulence factors expressed by MRSA strain include Panton-Valentine toxin (PVL)
(discussed below), phenol-soluble modulins (PSM), and the arginine catabolic mobile
element (ACME; Hao et al., 2012; Otto, 2010). PSMs are proinflammatory cytolytic
toxins. Seven PSMs are core genome encoded, but there is a novel PSM gene so far
detected on SCCmec types II, III and VIII, associated with HA-MRSA (Chatterjee et al,
2011; Monecke et al., 2012; Queck et al., 2009). This is the only SCCmec-encoded toxin
gene identified currently.
PSMs are produced by several staphylococcal species. However CA-MRSA
produces larger concentrations of PSMs compared to other S. aureus types (Wang et al.,
2007). CA-MRSA can apparently manipulate neutrophil signaling in the host to mediate
PSM pathogenesis (Clarke, 2010). The arginine catabolic mobile element (ACME) is a
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pseudo-SCC more commonly observed in Staphylococcus epidermis and Staphylococcus
haemolyticus than in Staphylococcus aureus (Shore & Coleman, 2013). However, it has
been identified in the genome of SCCmec IV type MRSA strains, in particular in the
USA300 strain of CA-MRSA that predominates in the USA (Hao et al,. 2012; Katayama,
Ito & Hiramatsu, 2000). ACME consists of arc and opp3 gene clusters that together
comprise an arginine deaminase pathway (Diep et al., 2008b). There have been some
suggestions that it may contribute to virulence of USA300 but reports from animal
models are conflicting (de Lencastre, Oliveira, & Tomasz, 2007; Montgomery, BoyleVavra, & Daum, 2009). Carriage of other toxins including staphylococcal enterotoxins
such as sec, sel, and sea, endotoxins and toxic shock syndrome toxin (TSST-1) varies
considerably between MRSA strains (Monecke et al., 2011).
Panton-Valentine toxin. Panton-Valentine toxin (PVL) is expressed in CAMRSA strains due to acquisition of the prophage-encoded adjacent lukS and lukF genes.
These genes encode the dual leukocidin PVL toxin parts, LukS and LukF (Chambers,
2005; Otto, 2013). PVL belongs to a β-barrel family of pore-forming cytolytic toxins also
containing several other leukocidins, gamma-toxin, and alpha-toxin (Szmigielski et al.,
1999). In 1932, Panton and Valentine noted that there was an association between PVL
production and abscess formation (Panton and Valentine, 1932). Recently, interest in
PVL has increased due to the epidemiological association between the lukSF genes and
CA-MRSA (Vandenesch et al., 2003). Most CA-MRSA strains contain lukSF genes.
They are present in MSSA at a much lower frequency and are absent from HA-MRSA.
PVL is now regarded as a relatively stable marker of CA-MRSA.
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Agr two-component system. Virulence and resistance are regulated by twocomponent systems in MRSA. Among the most important of these in controlling both
virulence and resistance is the agr system. Four agr groups (I-IV) have been identified in
MRSA, whose expressions vary with geography, antibiotic resistance profile, and
virulence factors. Agr plays an important role in quorum-sensing and contributes to
MRSA pathogenesis, including toxin expression, biofilm formation and heterogeneous
resistance (Hao, Dai, Wang, & Yuan, 2012). Generally speaking, agr type I correlates
with HA-MRSA and type II correlates with CA-MRSA while types III and IV correlate
to other conditions such as TSST-1 and staphylococcal scaled skin syndrome (Hao, Dai,
Wang, & Yuan, 2012; Nichol et al., 2011). Both agr types I and II are associated with
multidrug resistance (Hao, Dai, Wang, & Yuan, 2012; Nichol et al., 2011). Type I
predominates in Europe and South America while type II has been mainly found in Japan
and North America (Hao, Dai, Wang, & Yuan, 2012).
Antibiotic Resistance Profiles of MRSA
Antibiotic resistance of MRSA is mainly dictated by elements of the SCCmec. All
SCCmec elements carry genes that cause resistant to β-lactam antibiotics, in particular
mecA (Lim and Strynadka, 2002; Shore & Coleman, 2013). MecC is a more recently
identified homologue of mecA that also encodes β-lactam resistance (Garcia-Alvarez et
al., 2011). All SCCmec elements carry genes for resistance to β-lactam antibiotics, in
particular mecA, as well as mecRI and mecI genes for the regulation of expression of
mecA (Hao et al., 2012). In addition, SCCmec Types II and III carry non-β-lactam
antibiotic resistance genes on integrated plasmids and a transposon. These confer
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resistance to antimicrobials including aminoglycosides, macrolides, tetracycline,
mercury, and cadmium (Hiramatsu et al., 2002). This seriously complicates therapeutic
options in HA-MRSA and limits physicians to drugs such as vancomycin, linezolid,
clindamycin, sulfamethoxazole-trimethoprim, and rifampin (Monecke et al, 2011; So &
Farrington, 2008). All of these drugs have potential issues including ease of
administration, penetration, and toxicity (Monecke et al, 2011; So & Farrington, 2008).
Beyond this, new problems are arising with the emergence of vancomycinresistant Staphylococcus aureus (VRSA). There are both vancomycin-intermediate
Staphylococcus aureus (VISA) infections, in which HA-MRSA develops intermediate
resistance to vancomycin, and full VRSA (Chang et al., 2003; MMWR, 1997 & 2000;
Smith et al., 1999; Weigel et al., 2003). The resistance mechanisms are different and they
do not progress from one to the other along a resistance continuum. VISA is suggested to
result when an MRSA infection is intensively treated with vancomycin and as a result
undergoes mutation in cell wall biosynthesis genes. This leads to a thicker cell wall that
can partially exclude vancomycin, resulting in intermediate vancomycin resistance (Cui
et al., 2003). VRSA, in contrast, relies on co-infection with both MRSA and vancomycinresistant Enterococcus (VRE), with subsequent transfer of the vanA vancomycin
resistance gene on a plasmid or transposon from VRE to MRSA (Weigel et al., 2003). In
any case, the rise of these vancomycin-resistant MRSA strains is a worrying development
and has contributed to the continuing research efforts to identify new antimicrobials and
new delivery strategies to try to combat multi-drug resistant bacteria (Burke & Rose,
2014; Ndieyira et al., 2014).
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Examples of new antimicrobials in development include the lipoglycopeptides
oritavancin, telavancin, and dalbavancin. The pharmacokinetic and pharmacodynamic
properties of these drugs mean that they have shown promise in targeting vancomycinresistant MRSA (Burke & Rose, 2014). A new strategy for targeting antibiotics to try to
overcome resistance and optimize dosing includes use of nanoparticles (Ndieyira et al.,
2014). The multiplicity of MRSA strains and continual evolution of these bacteria make
development of new antimicrobials and therapeutic strategies imperative and also dictates
that there should be some consensus in typing and nomenclature of MRSA clones and
strains.
Overview of MRSA Strains
An overwhelming variety of both CA-MRSA and HA-MRSA strains have been
identified to date in humans, as well as many more that have been identified in livestock
(Monecke et al., 2011). Global epidemiology varies for these strains and there is a need to
harmonize methods and nomenclature used to describe strains in order to facilitate
surveillance, identification of risk factors and investigation of suspected outbreaks, and
identification of possible new strains (Stefani et al., 2011). At present, there is a
multiplicity of MRSA typing methods which will be discussed in more detail in the
succeeding sections. As summarized by Stefani et al., 2011, these include spa typing,
multilocus sequence typing (MLST), SCCmec sequencing, macrorestriction pattern
analysis, and multilocus VNTR analysis (MLVA). The genes targeted in these typing
methods and their main advantages and disadvantages are summarized in Table 2.
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Recently, researchers, involved in a major genotyping effort by DNA microarray
analysis in laboratories in nine different countries, proposed assigning of MRSA isolates
to 34 distinct lineages based on non-mobile genetic elements (Monecke et al., 2011).
Monecke et al. (2011) demonstrated that the epidemiological distribution of MRSA
strains could be approximately divided up into three groups based on PVL expression
(Monecke et al., 2011). PVL-expressing MRSA prevalence is low in Europe but high in
Australia and Abu Dhabi, while in the USA, one PVL expressing MRSA strain, termed
USA300, predominates over all other strains.
MRSA strains can be assigned to different clonal complexes based on a
‘fingerprint’ of core or core variable genes (Monecke et al., 2011). The most commonly
observed globally of these clonal complexes (CC) are CC5, CC8, CC22, CC30, and
CC45 (Monecke et al., 2011; Stefani et al., 2011). Within these clonal complexes lie
strains of both HA-MRSA and CA-MRSA. These strains have different names in
different countries, making it difficult to apply uniform approaches to surveillance and
treatment worldwide. One suggested nomenclature was to name strains by: sequence type
(ST)-MRSA-SCCmec type (Enright et al., 2002). This naming convention would be a
relatively simple and transferrable method; however assignment to strains in such a way
is also complicated by, for example, very different strains sharing the same ST and
SCCmec. Thus additional information, for example on PVL status, should also be
considered (Monecke et al., 2011).
Generally, prevalence of HA-MRSA is declining in some European countries or
remaining stable in others, but is present at very high rates in parts of East Asia (Stefani
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et al., 2011). Europe has remained relatively free of CA-MRSA, although there is now
evidence of steady increases in, for example, incidence of USA300, probably as a result
of international travel (Tietz, Frei, & Widmer, 2005). Meanwhile in East Asia, incidence
of CA-MRSA varies considerably from one country to the next (Song et al., 2011). In
terms of CA-MRSA, the number of cases has rapidly expanded in recent years in the
USA (Maree et al., 2007; Pan et al, 2003 & 2005; Labandeira-Rey et al., 2007). The
majority of cases can be assigned to strain USA300, which expresses the SCCmec type
IV and is PVL positive, considered classic hallmarks of CA-MRSA (Fridkin et al., 2005;
Pallin et al., 2008; Stefani et al., 2011). The other most commonly observed strain in the
USA was from CC5. PVL in these CA-MRSA strains were associated with increases in
necrotizing pneumonia (Gillet et al., 2007; Labandeira-Rey et al., 2007).
There is doubt now as to what can be classified ‘HA-MRSA’ and what can be classified
‘CA-MRSA’. s previously mentioned, the CDC advocates an exclusionary definition of
CA-MRSA based on the absence of health care-associated risk factors including surgery,
hemodialysis, peritoneal dialysis, hospitalization, residency in a long-term care facility
within the last year, or presence of indwelling percutaneous devices or catheters at the
time of diagnosis or previous isolation of MRSA (CDC, 2005). However, it is
increasingly recognized that boundaries are blurring in terms of discriminating between
HA-MRSA and CA-MRSA by way of health care-associated risk factors. This is because
patients diagnosed with a genotypically CA-MRSA infection, for example expressing
SCCmec IV and PVL, have shown to have exposure to a health care environment,
indicating spread of CA-MRSA into hospitals both in the USA (David et al, 2008a;
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Maree et al., 2007; Nair et al., 2011; Otter & French, 2011) and in Europe (Campanile et
al., 2011; Donnio et al., 2004; Hetem et al., 2012). In East Asia, there has been spread in
both directions, from the community to the hospital and from the hospital to the
community (Song et al., 2011).
It is clear that lack of international consistency in the use of typing methods and
classification of MRSA strains brings considerable challenges. These are relevant to the
issue addressed in this study, the establishment of a verified MRSA phenotyping method
supported by a genotyping ‘gold standard’ classification method for MRSA strains
isolated in the Saudi Aramco community. In terms of Saudi Arabia specifically, there
have not been many studies on characterization of locally relevant strains of MRSA. One
study, however, was carried out in the King Fahad Medical City in Riyadh on 102 patient
isolates (Monecke et al., 2012). These samples were subjected to genotyping by DNA
microarray analysis, resulting in identification of five different strains belonging to four
clonal complexes of great diversity. Consistent with the findings in other countries, there
was evidence of strains in the hospital-acquired samples which would be considered CAMRSA by the presence of PVL. In Table 2, I present the advantages and disadvantages of
MRSA typing methods.
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Table 2
MRSA Typing Methods and their Advantages and Disadvantages
Method

Genes targeted

Advantages

Disadvantages

Spa typing

Polymorphisms

Rapid, high throughput, Results in misclassification in

in the X region

portable, dynamic,

of the surface

standardized

protein P

nomenclature

some lineages

encoding spa
gene
MLST

Core and core

Defines the core

variable genes

genetic population;

Low throughput; expensive

portable; standardized
nomenclature
SCCmec

Mobile genetic

Standardized

Low throughput; expensive;

sequencing

elements

nomenclature

protocols are not standardized

PFGE

Whole

High discriminatory

Requires good technical skills;

chromosome-

index

portability limited; multiple

restriction

nomenclatures exist- not

polymorphisms

standardized; results in
misclassification in some
lineages

MLVA

Chromosomal

Rapid, high throughput No internationally standardized

VNTR

protocols or nomenclature;

polymorphisms

results in misclassification in
some lineages

Note. Adapted from Stefani et al., 2011.
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The following sections consider these phenotyping methods in more detail along
with currently available genotyping methods.
Phenotyping of MRSA
The most common phenotyping methods for assignment as HA-MRSA or CAMRSA belong to three categories, health care risk factors, infection type (CDC, 2005),
and susceptibility pattern (Clinical Laboratory Standards Institute (Clinical and
Laboratory Standards Institute), 2005). The health care risk factors method advocated by
the CDC (CDC, 2005) is a conservative method which dictates that CA-MRSA diagnosis
is based on the host's lack of health care risk factors. If such risk factors are present, it
advocates classification as HA-MRSA. Risk factors for HA-MRSA include surgery,
hemodialysis, peritoneal dialysis, hospitalization, and residency in a long-term care
facility within the last year, or presence of indwelling percutaneous devices or catheters
at the time of diagnosis or previous isolation of MRSA (CDC, 2005).
CA-MRSA is diagnosed when MRSA is observed in an outpatient or patient
within 48 hours of hospitalization that lacks the risk factors outlined for HA-MRSA
(Naimi et al., 2003). In terms of the infection method for phenotyping, there is overlap
with the health care risk factors method. Any MRSA isolated from deep wounds or sterile
body sites such as the blood, CSF, and pleural fluids from patients who have health care
risk factors comprising hemodialysis, surgery, residence in a long-term care facility or
hospitalization during the previous year, the presence of an indwelling catheter or a
percutaneous device at the time of culture, is labelled as HA-MRSA. MRSA isolated
from patients lacking those risk factors is labelled as CA-MRSA (CDC, 2005).
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Finally, the susceptibility pattern method refers to susceptibility to antibiotics.
As mentioned previously, HA-MRSA is associated with the larger SCCmec Types II and
III, which feature plasmids and/or transposons encoding antibiotic resistance genes
beyond the β -lactam antibiotic class. Thus, according to the susceptibility pattern
phenotyping method, MRSA cases that are resistant only to β-lactams antibiotics are
assigned to CA-MRSA while those that are resistant to additional antibiotics classes such
as carbapenems, aminoglycosides, and fluoroquinolones are designated HA-MRSA
(Clinical and Laboratory Standards Institute, 2005).
Accurate phenotyping and the ability to rapidly and efficiently assign MRSA
cases to HA-MRSA or CA-MRSA is important in monitoring trends in MRSA within
health care settings and in the community in different countries. Accurate phenotyping
directly affects choices of appropriate antibiotic treatment, monitoring of outbreaks, and
prediction or recognition of epidemics. The phenotyping methods described are widely
used within health care settings. Although each has some merit, the suitability of any
single method for all situations is now in doubt.
One complicating factor is the emergence of invasive and multidrug resistant CAMRSA strains in health care settings as a cause of health care associated infection (Gillet
et al, 2010; Seybold et al, 2006), both in the USA (David et al, 2008a; Maree et al., 2007;
Nair et al., 2011; Otter & French, 2011) and in Europe (Campanile et al., 2011; Donnio et
al., 2004; Hetem et al., 2012). There is also evidence of increased circulation of HAMRSA in the community (Miller et al, 2007; Seybold et al, 2006). In East Asia,
meanwhile, there is evidence of the spread of ‘HA-MRSA’ and ‘CA-MRSA’ from the
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community to the hospital and from the hospital to the community (Song et al., 2011). All
these factors would be expected to interfere with the sensitivity of the types of
phenotyping methods described and their concordance with each other. This interference
suggests a need to identify elements of the available phenotyping methods that would
offer increased sensitivity in local situations and show better concordance with
genotyping methods.
In my study, I aimed to examine the suitability of phenotyping methods in the
context of the Saudi Aramco community in the Eastern province of Saudi Arabia, test
their concordance, and identify phenotyping elements that would contribute to increased
sensitivity in diagnosis. I established concordance with information derived from a ‘gold
standard’ genotyping multiplex PCR method.
Genotyping of MRSA
There have been a variety of methods described for genotyping of MRSA, all of
which have their advantages and disadvantages (Biendo et al., 2013; Monecke et al.,
2011; Stefani et al., 2012; Tenover et al., 1994; Zimmerman et al., 2012). Some of the
genotyping methods currently in common use were summarized in Table 2. The success
of these methods depends on having an understanding of the basic genome structure of
Staphylococcus aureus, the variation between Staphylococcus aureus strains, and how
strains are evolving (Stefani et al., 2012). The basic genetic core of Staphylococcus
aureus consists of a highly conserved set of core genes interspersed with a set of
approximately 700 core variable (CV) genes, which are used to group Staphylococcus
aureus into lineages. Lineages are currently defined on the basis of multilocus
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sequencing type (MLST) clonal complexes (CC) from sequencing of a set of seven
housekeeping genes. This is the basis of the ‘sequence type’ (ST) designation in
Staphylococcus aureus terminology generally and MRSA terminology specifically.
Sequence type refers to single nucleotide polymorphisms in MLST sequences of these
seven housekeeping genes. Isolates that are identical will have the same ST number and
closely related STs will be grouped together in the same CC (Stefani et al., 2012).
However, as already mentioned, Staphylococcus aureus features mobile genetic
elements that are essential in the evolutionary success of Staphylococcus aureus strains,
as they carry genes conferring both increased virulence and resistance to antibiotics. The
key to how HA-MRSA and CA-MRSA fit into both the Ecological and ASP framework
of the current study is the mobile genetic elements of Staphylococcus aureus that have
driven the emergence of MRSA. Some genotyping methods for MRSA consider the
mobile genetic elements, particularly SCCmec, mecA, mecC, and PVL, as well as
additional antibiotic resistance genes conferred by plasmids and transposons. Major
methods currently used in MRSA genotyping are described in the following sections.
Pulse Field Gel Electrophoresis. Macrorestriction pattern analysis by PFGE is a
widely used genotyping method which scans the whole chromosome for restriction
polymorphisms. The method entails lysing the bacterial cell wall, embedding the
bacterial cells in agarose and partially digesting the bacterial DNA with a range of
restriction endonucleases before separating bands by electrophoresis. This method has
been validated epidemiologically and significant correlation has been observed between
phenotyping by antibiogram and genotyping by PFGE (Blanc et al., 2001; Chomvarin et
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al., 2005). PFGE is considered the gold standard MRSA genotyping method due to its
high discriminatory power (Blanc et al., 2001; Chomvarin et al., 2005; Deurenberg et al.,
2007).). However, it is a technically complicated and time-consuming, its portability is
very limited and there is no major consensus on nomenclature derived from the method
(Mehndiratta & Bhalla, 2012; Narukawa et al., 2009; Stefani et al., 2012). As it is an
image-based method, standardization and sharing of information between laboratories is
challenging.
Spa sequence typing. The spa gene of Staphylococcus aureus encodes the cell
wall component Staphylococcus aureus protein A (Deurenberg et al., 2007). This gene
consists of a number of 24 base repeats and exhibits polymorphisms which are exploited
in the spa sequencing genotyping method (Deurenberg et al., 2007). This method has
major practical advantages in terms of its high throughput, rapid turnaround, and lack of
extreme technical difficulty, as it only involves sequencing one locus and it benefits from
a standard nomenclature (Stefani et al., 2012). In some cases, it has been shown to have
good concordance with other genotyping methods including PFGE and MLST (Melin et
al., 2009; Narukawa et al., 2009; Strommenger et al., 2006) and its sensitivity is
considered to lie somewhere between these two methods (Deurenberg et al., 2007).
Development of the clustering algorithm Based Upon Repeat Patterns (BURP) has
facilitated cluster analysis based on spa sequencing data and been used to show
concordance of spa sequence typing with other methods (Deurenberg et al., 2007; Stefani
et al., 2012; Strommenger et al., 2006;). The spa server database, curated by the
SeqNet.org initiative contains information from thousands of spa sequences (Deurenberg
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et al., 2007; Stefani et al., 2012). Overall, spa typing is considered to be a good clinical
typing option. However, in some cases spa sequencing type leads to misclassification of
lineages and it lacks discrimination in local situations where one or a small number of
clones are endemic (Stefani et al., 2012).
Multi Locus Sequence Typing (MLST). MLST is a highly discriminatory
method used for analysis of clonal evolution of MRSA (Deurenberg et al., 2007; Stefani
et al., 2012) As previously mentioned it is used in sequence type (ST) typing in
Staphylococcus aureus and as such is associated with a standardized nomenclature
(Stefani et al., 2012). In MLST typing, seven housekeeping genes are sequenced and the
allele combination identified is used to assign an ST number to the isolate under
examination (Faria et al., 2008). Closely related STs will be grouped in the same clonal
complex (CC) (Faria et al., 2008; Stefani et al., 2012).
SCCmec typing. Methicillin resistance in Staphylococcus aureus is achieved via
the SCCmec that contains the mec A gene complex and the ccr gene complex. There are
currently eleven known SCCmec types ranging in size from 20 to 60 kb (Garcia-Alvarez
et al., 2011; IWG-SCC, 2009; Li et al., 2011; Shore & Coleman, 2013; Shore et al.,
2011). Each has been assigned a unique Roman numeral reflecting the order in which it
was identified (IWG-SCC, 2009). HA-MRSA is generally associated with expression of
SCCmec Types I, II or III while CA-MRSA is generally associated with Types IV and V.
Each SCCmec type encodes resistance to different antibiotics (Zhang, McClure, Elsayed,
& Conly, 2009).
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During the last two decades, several genotyping studies that target different genes
were conducted in the USA and Europe to accurately classify MRSA as CA-MRSA or
HA-MRSA, and to understand the molecular characteristics of the most predominant
strains. However, the same type of genotyping studies were not introduced in the Middle
East, and in particular in Saudi Arabia, until 2012 when the first genotyping study that
targeted different MRSA genes was conducted in the central province area of Saudi
Arabia to characterize and classify 107 MRSA strains that were isolated from 107
patients (Monecke et al., 2012).
HARMONY, the International Union of Microbiology Societies' European
Staphylococcal typing network, has suggested that a combination of MLST and SCCmec
typing should be used as a reference typing system for multicenter MRSA surveillance
MRSA (Cookson et al, 2007) and that it should be possible to integrate findings from
PFGE and spa typing- economically more affordable methods- with MLST and SCCmec
sequencing findings. MLST and SCCmec both have the disadvantage of being low
throughput and expensive methods (Stefani et al., 2012). A multi-typing approach is also
advocated by the European Centre for Disease Prevention and Control (ECDC) while
SeqNet.org urges standardization of laboratory methods to facilitate quality control and
comparability (Stefani et al., 2012).
Findings of an expert panel meeting held by the International Society of
Chemotherapy in 2011 suggested that within countries, there should be three levels of
typing laboratories at local, regional, and national levels, all with different functions and
using typing techniques appropriate to their function and available resources (Stefani et
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al., 2012). At the local level, where the main function should be new strain detection and
identification of species, time, location, and unusual characteristics, PCR-based methods
are suggested as they are rapid, relatively inexpensive, and readily communicated to labs
at regional and national level. PCR- based methods include multiplex PCR (M-PCR),
real-time PCR, hyper variable region (HVR) and the spa typing (Stranden, Frei, Adler,
Fluckiger, & Widmer, 2009). The method of choice in my study was based on multiplex
PCR.
Multiplex PCR. The technical basis of multiplex PCR is the use of multiple
oligonucleotide primers in the same PCR, which allows simultaneous amplification of
several target genes. In a study of MRSA, genes targeted included 16S rRNA, mecA and
PVL genes, giving rapid and reliable results for example in detection of USA300
(Bonnstetter et al., 2007).
Another study on mecA and coagulase genes showed excellent concordance
between disk diffusion tests to measure oxacillin susceptibility and mecA detection by
PCR, while results for coag detection by PCR were concordant with phenotypic tests for
all isolates (Rallapalli, Verghese, & Verma, 2008). Studies suggest that speedy detection
of MRSA using in-house or commercial PCR analysis is substantially compatible for
patient management (Malhotra-Kumar et al., 2008). The commercially available Gene
Xpert MRSA kit (Cepheid) uses a multiplex, real-time PCR method with primers. This is
designed to detect each SCCmec type as well as the chromosomal orfX-SCCmec
junction, which simultaneously gives information on both the SCCmec identity and on
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whether the SCCmec is correctly integrated with respect to orfX, thus confirming
methicillin resistance (Biendo et al, 2013).
A recent update to the Gene Xpert system simultaneously detects spa, thus
confirming the presence of Staphylococcus aureus, presence of mecA and the junction
between SCCmec and orfX, and overcoming previous drawbacks in the system that
falsely led to MSSA strains with an ‘empty’ cassette, lacking mecA, as MRSA (Biendo et
al., 2013). In blood cultures this method yielded genotypic results with excellent
concordance with phenotypic methods.
Thus, multiplex PCR methods seem to offer the advantages of rapidly obtainable
results that are concordant with phenotypic data. Among various other PCR based typing
techniques, random amplified polymorphic DNA (AP-PCR/RAPD), polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP) and multilocus variablenumber tandem repeat analysis (MLVA) are also suggested to be useful for typing of
MRSA strains.
AP-PCR/RAP. This rapid and straightforward technique is potentially applicable
to almost all MRSA strains (van Belkum et al., 1995). It involves use of small arbitrary
primers of unknown homology to the target sequence to randomly amplify the target
DNA segments. The number and size of the fragments produced during PCR are the
foundation for MRSA isolate typing of a MRSA isolate. In a study to evaluate AP-PCR
for Staphylococcus aureus typing, it was suggested that the technique could be useful in
studying outbreak strains but not for use as a reference method due to poor interlaboratory reproducibility (van Belkum et al., 1995).
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PCR-RFLP. This technique relies on amplifying a defined fragment of DNA
followed by consequent restriction enzyme digestion of the amplified product and
analysis of restriction fragment length polymorphisms (Mehndiratta et al., 2009; Stefani
et al., 2012). This method has been used on the coagulase (coa) and spa genes to
distinguish between MRSA strains (Mehndiratta et al., 2009). PCR-RFLP of spa gene in
particular has been reported to be valuable in differentiating between strains which were
otherwise difficult to type (Mehndiratta et al., 2009).
Multilocus VNTR analysis (MLVA). MLVA is a PCR-based method that relies
on the polymorphism of tandem repeated DNA sequences (Schouls et al., 2009). In terms
of MRSA it is seeing increasing use as it is a high-throughput, rapid method (Stefani et
al., 2012). However, there is some concern about reproducibility and nomenclature and
also there is a lack of any standard methodology, as a number of schemes are in use
(Stefani et al., 2012). Against these disadvantages, it has been shown that this method
potentially has a discriminatory power in excess of either spa or PFGE-based methods,
while at the same time showing good concordance with results from both of these
methods (Schouls et al., 2009).
Concordance of Phenotyping and Genotyping of MRSA
Generally accepted characteristics of HA-MRSA and CA-MRSA as inferred from
phenotyping and genotyping studies are summarized in Table 3. Phenotyping by criteria
including health care risk factors, infection type (CDC, 2005), and susceptibility pattern
(Clinical Laboratory Standards Institute (Clinical and Laboratory Standards Institute,
2005) have been widely used to classify MRSA into HA-MRSA and CA-MRSA.
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However, experience throughout the world of the spread of CA-MRSA into health care
settings and emergence of HA-MRSA in the community has challenged assignment of
MRSA purely in terms of the health care risk factor and infection type phenotyping
methods (Campanile et al., 2011; Hetem et al., 2012; Nair et al., 2011; Otter & French,
2011; Song et al., 2011). In Table 3, I present the characteristics of CA and HA-MRSA.
Table 3
Characteristics of CA-MRSA and HA-MRSA
Characteristic

CA-MRSA

HA-MRSA

Common
manifestations

SSTI, necrotizing pneumonia Nosocomial bacteraemia,
pneumonia, wound
infections

Antibacterial
susceptibility

Frequently susceptible to

Broad resistance to non-β-

non-β-lactam antibacterials,

lactam antibacterials,

low prevalence of iMLSβ

resistance common iMLSβ

resistance
SSCmec type

IV, V

I, II, III

Accessory gene
regulator type

agr III

agr I, II

Genotype (PFGE)

USA300, USA400,
USA1000, USA1100

USA100, USA200,
USA500, USA600,
USA800

Sequence type (MLST) ST1, ST8, ST30, ST59, ST80 ST5, ST36, ST45
Virulence genes/factors pvl, sea, seb, sec, seh and
Type I ACME common;
higher expression of PSM;
more rapid in vitro growth

pvl uncommon, Type I
ACME absent
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For example, in a study of 616 patients in University of Chicago hospitals, it was
found that many patients with health care risk factors carried MRSA that was
clindamycin-resistant, PVL positive, contained SCCmec IV and/or was assigned as ST8
by MLST, all features of CA-MRSA (David et al., 2008a). Therefore, exposure to health
care risk factors is becoming increasingly unreliable as a predictor of HA-MRSA versus
CA-MRSA. The result is that CA-MRSA becomes underestimated, as the risk factors and
infection type methods have a higher tendency to identify HA-MRSA than the
susceptibility pattern method or genotyping methods (Sievert 2008).
David et al (2008a) further confirmed that skin and soft tissue infections (SSTI)
are the most common types of infections for both CA-MRSA and HA-MRSA,
challenging the infection type phenotyping method. Genotyping methods such as
multiplex PCR and PFGE are highly reliable in classifying MRSA. It is imperative to
identify reliable phenotyping criteria confirmed with genotyping results and thus
dependable for use in the field. In some cases, concordance between phenotyping and
genotyping methods has been confirmed. For example, in a study where genotype of
MRSA was predicted using a fluoroquinolone susceptibility test, the results of
antibiogram and PFGE were significantly correlated suggesting that antibiogram can be
an effective tool for use as an epidemiological marker (Chomvarin et al., 2005).
Concordance between the Gene Xpert multiplex PCR genotyping method and
phenotyping by antibiotic susceptibility using the disk diffusion method has also been
recently shown (Biendo et al., 2013).
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The International Subcommittee on Phage Typing of Staphylococci standardized
phage typing as a phenotyping method in 1972. The challenge is to successfully
compromise between phenotyping and genotyping methods in a way that achieves the
most reliable results but is realistic in terms of available resources in local and regional
situations. Genotyping methods have long been recognized as more reliable when
compared to phenotypic methods (Weller, 2000). However, phenotyping criteria can be
tested against genotyping methods in order to choose the best combination of infection
type, risk factors and susceptibility pattern as the phenotypic characters of MRSA keep
changing constantly. The challenge in my study was to identify a verifiable MRSA
phenotyping method, supported by a genotyping ‘gold standard’ classification method,
for MRSA strains isolated in the Saudi Aramco community in the Eastern province of
Saudi Arabia.
Epidemiology of MRSA in Saudi Arabia
Prevalence of CA-MRSA has been rising in Saudi Arabia in recent years
(Monecke et al., 2012). As documented in other countries, healthy individuals have been
observed to acquire MRSA in the absence of health care associated risk factors
(Bukharie, 2010). For example, between 2000 and 2008 in the Eastern Province, CAMRSA infections increased dramatically in King Fahad Hospital (Bukharie, 2010). In
Dhahran Medical Centre, MRSA accounted for 6%. Meanwhile in the western province
of Saudi Arabia, the prevalence of CA-MRSA was found to be 15.8% of all MRSA
isolates (Bukharie, 2010). A study from seven hospitals in Riyadh indicates that among
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all Staphylococcus aureus isolates, the prevalence of MRSA ranged from 12% to 49%
and the prevalence in tested hospitals ranged from 27%–33% (Baddour et al., 2007).
Comparing all MRSA isolates, community-acquired infections comprise 62
percent (Al‐Tawfiq, 2006). The proportion of CA-MRSA dramatically increased from
41.7% in 1999 to 66.6% in 2002 (Bukharie, 2010a, p. 379). By 2008, 73% of MRSA
isolates were community acquired strains and the prevalence of CA-MRSA infections
rose from 9.9 per 10,000 admissions to 67 per 10,000 admissions between 2001 and 2008
(Bukharie, 2010a, p. 379).
Saudi Arabia lacks a MRSA national control program. A search of the National
Library of Medicine identified only 35 reports of MRSA infections in Saudi Arabia from
the year 1990 to April 2007 (Baddour et al., 2007). In contrast, the United Kingdom had
480 reports and United States 826 reports over a comparable period (Baddour et al.,
2007). Expert advice suggests that within countries there should be three levels of typing
laboratories at the local, regional, and national levels, with differing functions and using
typing techniques appropriate to their function and available resources (Stefani et al.,
2012). A classification scheme for Saudi Arabia which is appropriate for use at local,
regional, and national levels is needed to harmonize surveillance and treatment programs.
This classification scheme must be both practical and reliable. Current MRSA
classification criteria are not guaranteed to be accurate and misclassification is thus a risk.
For example, colonization with an infecting organism may last for months or years,
causing patients to be misclassified of having HA-MRSA infection, when they actually
acquired the endogenous MRSA strains from the community. In addition, patients with a
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prior history of MRSA infection may be labelled as having recurrent health careassociated infections, when the infection was acquired in the community (Stryjewski &
Chambers, 2008).
International experience suggests that health care risk factors has become a less
reliable indicator as CA-MRSA strains merge with health care settings and the
boundaries between ‘CA-MRSA’ and ‘HA-MRSA’ in terms of these types of risk factors
become blurred (David et al., 2008a; Diep & Otto, 2008). Even in terms of antibiotic
resistance typing, caution is needed. Despite the fact that the antibacterial susceptibility
phenotypes can distinguish between the CA- and HA-MRSA strains, still certain CAMRSA isolates have been observed to show rising resistivity to the antibiotics (David et
al., 2008a; Diep & Otto, 2008). A 2007 study showed that isolates of MRSA that were
phenotypically analogous to community associated strains have become predominantly
related with HA-MRSA (Maree et al., 2007).
Other pathological traits of CA-MRSA are not traditionally associated with HAMRSA, such as expression of certain toxins (Diep & Otto, 2008). For example, PantonValentine toxin (PVL) is expressed in CA-MRSA strains due to acquisition of the
prophage-encoded adjacent lukS and lukF genes which express it (Chambers, 2005; Otto,
2013). It is now regarded as a relatively stable marker of CA-MRSA and is proposed to
contribute to increased virulence of CA-MRSA. For example, PVL-expressing strains
have been associated with necrotizing pneumonia in previously healthy young people
(Gillet et al., 2007; Labandeira-Rey et al., 2007; Lina et al., 1999).
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PVL is a two-component leukocidin toxin that acts by forming pores in the
mitochondria (Genestier et al., 2005). By studying the MRSA genotypes from Riyadh
hospitals in the central province of Saudi Arabia, Moussa et al. (2009) found that, the
majority of strains of CA-MRSA carry the PVL genes and SCCmec type IV element
(Moussa & Shibl, 2009). More recently, in a study to characterize the population
structure of MRSA in Riyadh, microarray analysis was carried out on clinical and
environmental MRSA isolates collected in KFMC hospital (Monecke et al., 2012). A
great diversity of clonal complexes was identified and this study confirmed the
remarkable prevalence of PVL in the population as well as a high rate of antibiotic
resistance markers in community-associated strains.
Epidemiological studies, in addition to clinical data, would benefit from
molecular genotypic techniques and identification of various marker genes (e.g. SCCmec
type, virulence/toxin genes) to achieve a complete and reliable characterization of MRSA
isolates in Saudi Arabia. Standard definitions for CA- and HA-MRSA should be used
whenever possible, including molecular genotype assignment, SCCmec type, and the
presence or absence of various genes such as PVL, type I ACME and agr type.
Since some phenotyping methods for identification of MRSA strains and
antibiotic resistance detection can take more than 48 hours, molecular based genotyping
techniques such as those discussed above are used for fast and accurate identification and
characterization of MRSA isolates (Fluit, Visser, & Schmitz, 2001). To date, among all
the genotyping methods, PFGE is recognized as the ‘gold standard’ and is the most
extensively used typing technique. (Fluit, Visser, & Schmitz, 2001). PFGE is often
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coupled with other molecular typing techniques as a reference method, as it is the most
sensitive and specific so far (Molina et al., 2008). Within the last decade, numerous
different genotyping methods have been devised and used to distinguish among MRSA
types, as described in the section ‘Genotyping of MRSA’.
Before the development of PCR, several efficient typing methods were used,
which include bacteriophage typing, capsular typing, PFGE, and zymotyping, for
discriminating between MRSA strains (Weller, 2000). PCR-based methods are fast and
reliable methods, relatively inexpensive, and have high throughput. Therefore, they are
considered a method of choice for typing of strains at a local level (Stefani et al., 2012).
For my research, I used a multiplex-PCR method as a ‘gold standard’ genotyping method
against which to measure concordance of proposed phenotyping criteria for use in MRSA
classification in local situation of the Saudi Aramco community in the Eastern province
of Saudi Arabia. It was thus in line with expert international recommendations (Stefani et
al., 2012).
Future Considerations
Staphylococcus aureus is a human pathogen that can be found everywhere around
us and thus contributes a significant fraction of our public health history (Monecke et al.,
2011). . This bacterial organism has developed mechanisms to escape different
antimicrobial agents and continues to evolve to ensure its continued existence (Monecke
et al., 2011; Stefani et al., 2012). On the basis of current epidemiological data, the
incidence and prevalence of MRSA will persist and increase (CDC, 2005). The
intermixing of risk groups and environments for HA-MRSA and CA-MRSA has already
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begun and boundaries are blurring between the two. Thus an evidence-based
characterization and understanding of the existing epidemiology of MRSA is indicated,
so that the changes can be tracked and described appropriately. Without this knowledge
valuable and successful interceptive and preventive programs cannot be developed or
implemented. The accurate assessment of MRSA will be the cornerstone to implement
community-based control strategies. These strategies will be designed to minimize the
ability of MRSA strains to be transmitted from the community into the health care
settings. Also, these strategies will help determine the best approach for containing and
preventing the spread of CA-MRSA within the community.
Summary
In this chapter, I covered major themes in the current literature on MRSA with a
view to placing my research project in context. The purpose of my study was to establish
a set of verified MRSA phenotyping variables, supported by a genotyping ‘gold standard’
classification method, for MRSA strains isolated in the Saudi Aramco community in the
Eastern province of Saudi Arabia. Results of this study allowed reliable classification of
MRSA as HA-MRSA or CA-MRSA. The literature review included a historical overview
of the worldwide emergence of HA-MRSA and CA-MRSA, of the problem of multiple
drug resistance and research aiming to identify new antibiotics and treatment options.
The issue of the multiplicity of MRSA strains and variations in worldwide
geographic distribution was covered, including an update on current knowledge of
MRSA phenotypic and genotypic data within Saudi Arabia. Considering the worldwide
increase in cases of CA-MRSA and the challenges inherent in introducing international
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consistency in the use of typing methods and classification, I highlighted the importance
of establishing a reliable and inexpensive classification method for use in Saudi Arabia.
The new classification method would, in turn, expedite accurate diagnoses and
administration of appropriate treatment, and help identify outbreaks and epidemics in a
timely fashion. To place genotypic studies in context and show the importance of
genotypic identification in accurately classifying MRSA, the genetic elements of MRSA
were reviewed with special attention to the staphylococcal cassette chromosome mec
(SCCmec) and Panton-Valentine leuokocidin (PVL) genes. Current phenotyping and
genotyping methods and concordance or discordance between them were also reviewed.
Limitations in the methods were considered. In particular, the challenges inherent
in classification of MRSA as ‘HA-MRSA’ and ‘CA-MRSA’, given the limitations of
phenotyping methods, such as the health care risk factors method advocated by the CDC,
were addressed. These limitations helped me to demonstrate the necessity of identifying
phenotypic methods that give results that are concordant with genotyping data in the
specific context of the Saudi Aramco community in the Eastern province of Saudi Arabia.
Overall, while many studies exist on the risk factors, epidemiology, and genetics of HAMRSA and CA-MRSA, there are few studies specifically addressing the situation in
Saudi Arabia. The literature review presented in this chapter contextualized the need for
testing of the current phenotyping methods against a ‘gold standard’ genotyping method
in the Eastern province of Saudi Arabia.
I describe the methodology I used to answer my research questions in chapter 3.
This included samples and data to be used, a description of the three most commonly
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used phenotyping methods, health care risk factors, infection type, and antibiotic
susceptibility; the multiplex PCR genotyping data; analysis of concordance of data from
each phenotyping method with each other and with genotyping data; and sensitivity and
specificity of the three methods. I also identified the combination of MRSA phenotypical
classification methods or individual variables that best predict HA- and CA-MRSA in
Saudi Arabia’s Eastern Province, compared to the multiplex-PCR data.
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Chapter 3: Research Method
The purpose of this quantitative, secondary data analysis study was to characterize
the MRSA strains within the Saudi Aramco community and to accurately identify MRSA
strains infection as HA-MRSA or CA-MRSA by comparing and contrasting the three
existing phenotyping methods against a gold standard Multiplex PCR method. The
phenotyping methods tested were the health care risk factor, infection type (CDC, 2005),
and antibiotic susceptibility pattern methods (Clinical and Laboratory Standards Institute,
2005).
In this chapter, I explain the overall rationale for the selection of the study design,
and I describe the study population, sampling methods, and the data collection
procedures. Next, I discuss the methods I used to address each of the four research
questions.
Research Design and Rationale
My study was a quantitative, secondary data analysis. The aim of the research was
to characterize the two forms of MRSA infections, HA-MRSA and CA-MRSA, in the
Saudi Aramco population. Compared with cohort studies that are usually used to study
incidence, causes, and prognoses and are preferred when the exposures or the risk factors
are rare, case control studies are not suitable to measure multiples outcomes, always need
controls, and are more suitable when the outcomes are rare (Newman, 2001). A cohort
approach would have been preferable in this study; however, because I used secondary
data to determine exposures and outcomes concurrently, my research study was cross-
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sectional. Quantitative studies using secondary data are useful for establishing
associations rather than causality and for determining prevalence, rather than incidence;
further, they are appropriate when the outcomes are frequent, such as with MRSA
infection (Newman, 2001). This research design was appropriate for this study because it
assessed the prevalence of HA-MRSA and CA-MRSA within the Saudi Aramco
population through a rapid characterization of HA- and CA-MRSA infections using preexisting datasets. The selected design provided a method to assess the relationship
between various diagnostic methods across a large population in a system in which it
would be unethical to perform controlled experiments.
A combination of methods was used to relate demographic characteristics of the
patient population to MRSA infection phenotype and genotype. This combination of
methods generated novel findings regarding the specificity and sensitivity of affordable
phenotypic tests for differentiating HA- and CA-MRSA by comparing them with the
genotypic gold standard (Newman, 2001).

Study Population
The samples for this study were collected from patients attending the John
Hopkins Aramco Health Center, a 405-bed, acute-care hospital in Dhahran city, in the
Eastern Province of Saudi Arabia. The samples were from patients in the study
population, approximately 350,000 people who are employees, or dependents of the
Saudi Aramco Energy Corporation, which is headquartered in Dhahran (Saudi Aramco,
2014). Most of the population is of Asian origin, being either Saudis or nationals of other
Arab or Asian nations; expatriates from Western countries are a minority.
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Power analysis
For this study, all the available data for the period between January 2012 and
December 2013, 133 MRSA samples, were used. The power of the study to measure the
predictive ability of the model created in response to the final research question was
constrained by this fixed sample size. Power is the ability to detect a difference if one
exists and specifically relates to the ability to reject the null hypothesis (Newman, 2001).
Research Question 4 was the only question in this study with a null and alternative
hypothesis, so I conducted a power analysis for logistic regression with the parameters, α
= .05, effect size = .15 (medium effect size), and a maximum of eight predictors using
G*Power® ((Erdfelder, Faul, & Buchner, 1996). The resulting power from this
calculation was .99 and the associated x-y plot is presented in Figure 2.

Figure 2. X-Y plot of power based on sample size.
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Generally, to reject the null hypothesis, a p Value of .05 is needed. A power of at
least 0.8 is commonly considered desirable. Therefore, I could detect a medium
difference (effect size = .15) in predictive ability between multiple logistic regression
models with a sample of 133.
Data Collection
After attaining formal approval from the Saudi Institutional Review Board, I
obtained secondary data from all samples isolated between January 1, 2012, and
December 31, 2013, and I stored them in epidemiology and microbiology databases at the
Johns Hopkins Aramco Health Center. This time corresponded to the period when the
health center began collecting all MRSA samples to validate the multiplex PCR system,
for which all isolated MRSA samples were analyzed for the PVL and mecA genes.
Staphylococcus aureus infections were tested for sensitivity to the following antibiotics:
penicillin, oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin,
erythromycin, quinipristin, linezeloid, vancomycin, and tetracyclin. Samples were
defined as MRSA if the Staphylococcus aureus strain was found to be resistant to
cefoxitin; it was assumed that they were also resistant to oxacillin. However, the
molecular biologists who analyzed the original samples during data cleaning procedures
were further excluded 24 cases , due to borderline resistance to oxacillin. Other data
cleaning criteria during the original data collection efforts included samples with no
definition of infection site and colonization.
The epidemiological data included the following independent variables: health
care risk factors, hospital admission profile, whether they had been hospitalized for at
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least 48 hours prior to diagnosis or had been transferred from a different hospital,
infection type or bodily location of the infection, and antibiotic susceptibility profile.
They also included the covariates age, gender, survival status, and pre-existing illnesses.
Table 4 presents a sample data line.
Table 4
Sample Data Line
Variables

Sample values

Date

13 Jun

MR
Age

Boy

Gender

Male

Health risk factors

HCA

Infection

Pneumonia

Type

Sputum

Hospitalized

No

Visited clinic during the last year

Yes

Survival

Yes

Pre-existing illness

DM

P

≥ 0.5R

OX

≥4

GM

≤0.5

CIP

≥8

LEV

≥8

MOXI

≥ 8 continued
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Table 4 continued
Variables

Sample values

CC

≤ 0.25

E

≥8

Quini

≤ 0.25

Vance

15

Tetra

≤1

Tigecy

≤ 0.125

Rif

≤ 0.5

Bacterial samples were stored by the molecular biology and microbiology
divisions at the Johns Hopkins Aramco Health Centre (formerly Dhahran Health Center),
and Multiplex PCR methods were carried out on these samples to allow genotyping
information to be extracted. The extraction and analysis of the genotypic information
formed part of the methodology of this study (Appendix A).
Study Variables
The major classification variables in this study were the three phenotyping
methods: health care risk factors, infection type, and antibiotic susceptibility. These are
presented in Table 5.
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Table 5
Study Variables
Variable name

Source

Potential
responses

Level of measurement

Gender

Medical
records

Male
Female

Dichotomous

Race

Medical
records

Asian
White
Black

Categorical

Age

Medical
records

Age in years

Continuous

Survival

Medical
records

Yes
No

Dichotomous

Pre-existing condition,
Any of the following:
Diabetes (DM)
Chronic Renal Insufficiency
Dialysis
Cardio-vascular Disease (CVD)
Coronary Heart Failure
COPD

Medical
records

Yes
No

Dichotomous

Medical
Health care Risk Factors:
records
Surgery Hemodialysis
Peritoneal dialysis, Hospitalization,
Residency in a long-term care
facility within the last year
Presence of indwelling
percutaneous devices or catheters
at the time of diagnosis or previous
isolation of MRSA

Yes
No

Dichotomous

continued
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Table 5 continued
Variable name
Infection type:
Bacteremia
Pneumonia
Skin/Soft Tissue
Surgical Site

Source
Medical
records

Potential
responses
Type

Level of measurement
Categorical

Drug resistance:
Ciprofloxacin
Clindamycin
Gentamicin
Levofloxacin
Trimeth-Sulfamethoxazole

Sensitivity
test results

Yes
No

Each type is recorded as
a Dichotomous variable
as there may be more
than one per sample

Classification

Genotyping
and
phenotyping

HA-MRSA
CA-MRSA

Dichotomous

The operational definitions of the health care risk factors and infection type
methods were as defined in the CDC criteria (CDC, 2005). The following sections
explain in detail how each variable was measured and used to designate samples as ‘HAMRSA’ (HA=1) or ‘CA-MRSA’(CA=0). These designations were then used for
concordance/discordance analyses, as described in detail in the relevant sections of the
Data Analysis.
Classification by Health Care Risk Factors
Health care risk factors phenotyping is currently the methodology used at the
Johns Hopkins Aramco Health Center for designation of MRSA as HA or CA. Cases
were labelled as HA-MRSA in the hospital database on the basis of health care risk
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factors if the patient had at least one of the following established risk factors:
hospitalization >48 hours prior to the current infection (the patient was not MRSAinfected at the time of hospitalization but culture and infection were identified > 48 hours
after admission), presence in an intensive care unit (ICU) >48 hours prior to the current
infection, hospitalization in the previous year (admitted and discharged from a hospital at
any time during the year prior to the current infection), surgery during the previous year,
dialysis during the previous year, presence of a percutaneous device or indwelling
catheter in the previous year, and status as a resident of a long-term care (LTC), nursing
home or rehabilitation facility in the previous year (CDC, 2005).
Cases with none of the established factors for all seven HA-MRSA risk factors
were considered CA-MRSA (Naimi et al., 2003). For the purposes of this study, in order
to verify that the classification as HA-MRSA or CA-MRSA was correct, I re-assessed the
electronic and/or physical records for each sample and verified that the designation was
made correctly on the basis of at least one of the established risk factors being present for
a designation of HA-MRSA, or none being present for a designation of CA-MRSA.
Classification by Infection Type using Clinical Information
As stated previously, the samples were classified in the database as HA-MRSA or
CA-MRSA according to the health care risk factors method, which is the current standard
method used in the Johns Hopkins Saudi Aramco Health Centre. In this study, I classified
the cases by the infection type method using clinical data available in the hospital
database as follows. A sample was designated as CA-MRSA on the basis of infection
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type if a skin or soft tissue infection was diagnosed, including abscess, cellulitis,
folliculitis, and impetigo, or if a wound infection had “skin” identified as the culture site.
Cases with other, more serious infections, including bacteremia, meningitis,
osteomyelitis, pneumonia, septic arthritis, and surgical site infection, were labelled as
HA-MRSA (CDC, 2005). CA-MRSA can in some situations cause more serious
infections like pneumonia or bacteremia, but these infections are typically caused by HAMRSA and are usually accompanied by the HA-MRSA risk factors listed previously.
Therefore, if a case had both a skin or soft tissue infection and more invasive infection
concurrently, it was considered HA-MRSA to give more weight to the more serious
infection type (David et al., 2008). This allowed distribution of HA-MRSA and CAMRSA by the infection type method to be defined by the variable described above and
the results compared to the other two methods.
Classification by Susceptibility Pattern Using Clinical Information
The operational definition of the antibiotic susceptibly method was according to
the CLSI criteria (Clinical and Laboratory Standards Institute, 2005). Cases were
classified as HA-MRSA or CA-MRSA by the antibiotic susceptibility pattern method
using clinical data available in the hospital database as follows. Staphylococcus aureus
samples were primarily tested for antibiotic sensitivity using the VITEK II system. All
the antibiotics mentioned in the ‘Data collection’ section were tested. VITEK II tests for
sensitivity were performed by calculating the minimum inhibitory concentration (MIC) of
each drug, and the interpretation of each MIC value is assessed based on the Clinical
Laboratory Standards Institute (CLSI) guidelines. Cases were classified as CA-MRSA on
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the basis of susceptibility patterns if their isolates were resistant only to β-lactams. This is
the basic resistance pattern that defines MRSA (Clinical Laboratory Standards Institute
(Clinical and Laboratory Standards Institute, 2005). Cases were labelled as HA-MRSA if
resistance to additional antimicrobial classes beyond β-lactams was also reported. This
higher resistance included, but was not limited to, aminoglycosides, folate pathway
inhibitors, lincosinamide, fluoroquinolones, and tetracyclines (Naimi et al., 2003). This
allowed distribution of HA-MRSA and CA-MRSA by the antibiotic susceptibility
method to be defined by the variable described above and the results compared to the
other two methods.
Data Analysis
Statistical analyses was carried out using SPSS® 21 statistical software (IBM,
2012). The description of the study design was divided into four sections, each pertaining
to one of the primary questions I addressed in this research. In Table 6, I present how I
used each of the study variables to answer the four research questions.
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Table 6
Use of Study Variables per Research Question
Research question

Variable(s)/Type of

Type of

variable/Level of

analysis

Statistical tests

measurement
1. What is the genotypic distribution

Age/NA/Continuous

Univariate

Mean and

of MRSA in a sub-population of Saudi

Standard

Arabia’s Eastern Province?

Deviation
Gender, hospital admission

Frequencies

profile, survival,
preexisting illnesses, health
care risk factors,
susceptibility profile(each
drug) /NA/Dichotomous
Infection

Frequencies

type/NA/Categorical
2. What is the concordance between

Genotype Classification as

each pair-wise combination of the

HA-MRSA and CA-

three phenotyping methods, health

MRSA/

care risk factor, infection type, and

Dependent/Dichotomous

susceptibility pattern, used to classify
CA- vs HA-MRSA in Saudi Arabia?

Bivariate

Cohen's Kappa

Three Phenotyping
Methods' Classification as
HA-MRSA and CAMRSA/Independent/
Dichotomous

continued
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Table 6 continued
Research question

Variable(s)/Type of

Type of

variable/Level of

analysis

Statistical tests

measurement
3. What is the sensitivity and

Genotype classification as

specificity of each phenotyping

HA-MRSA and CA-

method (health care risk factor,

MRSA/Dependent/

infection type, susceptibility pattern)

Dichotomous

Bivariate

Sensitivity and
specificity

used to classify CA-MRSA vs HAMRSA in Saudi Arabia?

Three phenotyping
methods' classification as
HA-MRSA and CAMRSA/Independent/
Dichotomous

4. Is it possible to predict HA-MRSA

Health Care Risk Factors

and CA-MRSA in the Eastern

Multivariate

Multiple

Block 1

logistic

Province of Saudi Arabia using a

regression

combination of MRSA phenotypical
classification factors?

Infection Type

Susceptibility Pattern

Multivariate

-2 Log

Block 2

Likelihood

Multivariate

Hosmer and

Block 3

Lemeshow

Age/Independent/

Multivariate

Continuous;

Block 4

Gender, hospital admission
profile, survival,
preexisting
illnesses/Independent/
Dichotomous
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Research Question 1
What is the genotypic distribution of MRSA in a sub-population of Saudi Arabia’s
Eastern Province?
I previously carried out multiplex PCR on the stored 133 MRSA samples in the
molecular biology department in the Johns Hopkins Aramco Health Center study to
identify and classify circulating MRSA using the gold standard molecular method
(Popovich, 2007). For this study, I classified the samples as CA-MRSA or HA-MRSA
according to their mec-A and pvl gene sequences from the results of the multiplex PCR
assay. The multiplex PCR methodology was summarized in appendix A. Demographic
distribution and clinical information were obtained by matching PCR results to patient
information records from the Johns Hopkins Aramco Health Center database. Univariate
analysis, including mean and standard deviation for continuous variables and frequencies
for dichotomous and categorical variables, was carried out to determine the distribution
of HA-MRSA and CA-MRSA as defined by multiplex PCR genotyping results by age,
gender, health care risk factors, infection type, hospital admission profile, survival,
preexisting illnesses, and susceptibility profile.
The validity of the genotype assignment I used to answer Research Question 1
depended on the accuracy of the PCR genotyping. The method used is standard and well
tested, and little error was anticipated (Popovich, 2007; Stefani et al., 2012).
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Research Question 2
What is the concordance between each pair-wise combination of the three phenotyping
methods, health care risk factor, infection type, and susceptibility pattern, used to classify
CA- vs HA-MRSA in Saudi Arabia?
All cases in the epidemiology dataset were defined as either HA-MRSA or CAMRSA using one of three phenotyping classification criteria: health care risk factor,
infection type, and susceptibility pattern (Sievert, 2008; Sievert et al., 2010). Covariates
were age, gender, survival status during MRSA infection period and pre-existing illnesses
(specifically diabetes mellitus, chronic renal insufficiency, dialysis, cardiovascular
disease, chronic heart failure, and chronic obstructive pulmonary disease). Thus, I used
three criteria to classify MRSA type and assessed the similarity between classifications
based on these three different characteristics.
I conducted univariate and bivariate analysis to compare the demographic and
clinical distributions for the MRSA samples in the Saudi Aramco community, based on
HA-MRSA and CA-MRSA.
I defined frequencies and percentages for each of the phenotyping characteristics,
gender, health care risk factors, infection type, hospital admission profile, survival,
preexisting illnesses, and susceptibility profile. In addition, I evaluated the distribution of
age to assess for any patterns. For concordance analysis, I designated samples as HAMRSA or CA-MRSA and compared results for each of the three phenotyping methods to
each other to determine concordance or discordance. I considered p≤ 0.05 a statistically
significant difference.
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Concordance Analysis. I constructed a concordance matrix similar to published
literature (Sievert, 2008; Sievert et al., 2010) to examine agreement (i.e., concordance)
among all three phenotypic methods and each pair of methods for the Saudi Aramco
community specifically. This matrix contained the number and percentage of MRSA
cases identified as HA-MRSA or CA-MRSA by all three phenotypic methods, those that
were concordant between the three methods. The matrix also denoted the number and
percentage of cases identified as HA or CA by each pair of methods or by only one
method. The use of all three phenotyping methods and the inclusion of covariates was
used to confirm the overall distribution of HA-MRSA and CA-MRSA in the population
and added to the validity and reliability of the study instrument. For example in the USA,
all three methods yielded demographic, clinical, and microbiological variable
distributions that were consistent with patterns in the literature (Sievert et al., 2010).
In addition, Cohen’s kappa and its associated confidence interval was calculated
for each pair of methods, to provide a metric of concordance that accounted for the fact
that sometimes two methods can agree by chance alone (Kwiecien et al., 2011). Thus, the
Cohen’s kappa measured the normed difference between the rate of agreement that is
actually observed between the phenotypic methods and the rate of agreement that one
might expect purely by chance (Kwiecien et al., 2011). For a given pair of methods,
health care risks, infection type and susceptibility pattern, a two-by-two table was
constructed denoting the number of cases identified as HA and CA by each method. Then
marginal values, column and row totals, were calculated.
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The probability of agreement, po, is propA + propD. However, we would expect
agreement at random with some probability, pE (Kwiecien et al., 2011). This can be
calculated as the probability with which each method classifies the case as HA
independently plus the parallel probability for CA.
pE = propAB*propAC + propBD*propCD
The excess agreement, beyond chance, is then pO-pE. This value is normalized to
calculate the final Cohen’s kappa according to the following equation:
Cohen’s kappa = p0-pE/(1-pE).
The 95% confidence interval for Cohen’s kappa is calculated according to the
following equation:
CI = Cohen’s kappa +/- 1.96*sqrt ((p0(1-p0)/ (n(1-pE)^2))
Research Question 3
What is the sensitivity and specificity of each phenotyping method (health care risk
factor, infection type, susceptibility pattern) used to classify CA-MRSA vs HA-MRSA in
Saudi Arabia?
The sensitivity and specificity of each phenotyping method was measured using a
conventional two-by-two table. Multiplex PCR genotyping served as the gold standard
method. For each phenotyping method, I calculated the sensitivity, which is the
proportion of actual positives that are detected, as the number of infections identified as
positive by both phenotype and genotype, true positives, divided by the number of
infections that were identified as positive by genotype alone based on the gold standard
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and representing the true number of infections in the population (Newman, 2001).
Specificity, which is the proportion of actual negatives that are detected, was calculated
as the number of infections identified as negative by both the genotype and phenotype
tests, true negatives, divided by the number of infections that were identified as negative
by genotyping alone representing the true number of patients infection-free (Newman,
2001).
I also calculated 95% confidence intervals for these proportions, assuming
normally distributed error around the estimated sensitivity and specifity, p_hat.
This can be written as:

, where n is the number of observations.
Research Question 4
How well does a combination of demographic and phenotyping variables of the current
three phenotyping methods (health care risk factors, infection type, and susceptibility
pattern) predict MRSA genotyping classification as CA-MRSA or HA-MRSA?
H0: Demographic and phenotyping variables do not significantly predict MRSA
genotyping classification.
Ha: Demographic and phenotyping variables significantly predict MRSA
genotyping classification.
I used bivariate statistics, including chi-square and t tests to test the sensitivity and
specificity of the HA/CA designations generated from each of the major classification
variables, health care risk factors, infection type and antibiotic susceptibility, against the
outcome variable, HA/CA status based on the genotypic Multiplex PCR test. My main
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aim was to validate each phenotyping method against the genotyping method to
determine if one of the methods is optimally concordant with the genotypic method in
designating samples as HA-MRSA or CA-MRSA.
However, if one or more methods demonstrated superior sensitivity and
specificity, I further explored the potentially contributing parameters/variables. For
example, the susceptibility method depends on ten or more antibiotics; however, a subset
may be identified as crucial.
In the first instance, the statistical significance between the outcome variable and
the predictor variables was established by calculating the bivariate correlations of all the
possible predictor variables in order to determine those that are significant, age, gender,
health care risk factors, infection type, hospital admission profile, survival, preexisting
illnesses, and susceptibility profile. The magnitude of the odds ratios were also
established using SPSS® to compute a multivariate logistic regression model, with all
possible predictor variables initially and a backward conditional method to determine the
final model.
Having established the predictive ability of each phenotyping method, I used
Multiple Logistic regression. This allowed me to assess the best combination of
phenotypic characteristics to predict whether an infection was HA or CA. The response
or outcome variable was HA/CA status based on the genotypic Multiplex PCR test, while
each of the three classification schemes, health care risk factors, infection type, and
antibiotic susceptibility profile, was treated as separate dichotomous classification
predictor variables and entered into the model in blocks (Sievert, 2008). Combinations of

91
these variables were tested to identify the model with the best fit and predictive power.
The three methods introduced into the model using separate blocks and a backwards
conditional approach allowed me to parse the model and include only those variables
from across the three methods in a final model that could be recommended for testing in
the Saudi Aramco population. For example, combining individual antibiotic
susceptibilities from the susceptibility method with the infection site information could
result in a model with increased predictive power over that generated by a model that
uses either of these phenotyping methods alone.
Other predictor variables, added to the model generated from testing of the base
classification variables were age, gender, survival status during MRSA infection and preexisting illnesses (yes, if reported any of the following: diabetes mellitus, chronic renal
insufficiency, dialysis, cardiovascular disease, chronic heart failure, chronic obstructive
pulmonary disease; no, if none of these reported). These constituted an additional block
of variables and were therefore controlled for in the final model. Each of the models
produced were compared for best fit using -2 log Likelihood, and the final model's
relative predictive power using Hosmer and Lemeshow (Newman, 2001). I presented the
variables included in each block of the logistic regression in Table 7.
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Table 7
Variables in Each Block
Block

Independent variable(s)

1

Health Care Risk Factors: Surgery,
hemodialysis, peritoneal dialysis,
hospitalization, residency in a long-term care
facility within the last year, presence of
indwelling percutaneous devices or catheters at
the time of diagnosis or previous isolation of
MRSA

2

Infection Type: Bacteremia, Pneumonia,
skin/soft Tissue, surgical site

3

Antibiotic Susceptibility: Ciprofloxacin,
Clindamycin, Gentamicin, Levofloxacin
Trimeth-Sulfamethoxazole

4

Covariates: Age, gender, hospital admission
profile, survival, preexisting illnesses
The link function was the logit function, defined as:
Logit transformation: ln(mu/(1-mu))
The full model, which included the listed clinical and demographic characteristics

as covariates, was as follows:
Genotype = β1*I(ph1) + β2*I(ph2) + β3*I(ph3) + β4*(ph1xph2) + β5*(ph1xph3) +
β6*(ph2xph3) + β7*age + β8*gender + β9*survival status + β10*pre-existing illness,
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where the βs are the coefficients, I is an indicator function, ph1 refers to phenotype 1
(health care risk factors method), ph2 to phenotype 2 (infection type), ph3 to phenotype 3
(antibiotic susceptibility), etc., and (ph1xph2) indicates an interaction term.
The results of this model yielded the combination of phenotype variables that best
predicted genotype, and therefore CA/HA status. The model could then be applied to the
study population in the future to quickly and cheaply assess the HA/CA status of a new
MRSA case without requiring the time-consuming and expensive procedure of
genotyping. The sample size was adequate to conduct multiple comparisons, as needed
using Bonferroni to adjust the p value (Newman, 2001). As the main outcome of this
research question was the predictive ability of the models, I was not as concerned with
the p-values of the individual variables.
Threats to Internal and External Validity
The major threats to internal validity included discrepancies in the medical
records, missing information, and information bias. The use of secondary data introduced
the potential for misclassifications and missing data, which could contribute bias to
outcomes. The potential for information bias could have resulted from non-uniform
criteria on the part of health care providers. Health Care professionals have different
levels of medical record specificity and accuracy. Individual effort and competency
played a role in the completeness of each patient's individual medical records.
While I planned to compare the patient population at the Saudi Aramco facility to
the patient population in other facilities in the area, I could not ensure that the samples I
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used for this research were representative. This could result in a threat to external validity
and reduced my ability to generalize the results.
Ethical Considerations
In order to gain access to the data set, I followed the procedure of applying for
Saudi IRB approval through a Saudi Aramco IRB representative. The Saudi IRB is a
comittee founded by Saudi Aramco Health Center with the aim of encouraging research.
The request was reviewed and I was interviewed to explain the purpose the study. The
research was approved and I received an official written approval (see Appendix B).
Since the present study had no direct recruitment of any human or animal subject and did
not include identifying information regarding the patients, I applied for an expedited IRB
review from Walden University. This application was in addition to the official Saudi
IRB written approval I had already acquired (see Appendix B).The data continued to be
maintained in a secure fashion; the database that contains patient information collected
from different resources was stored on a computer without an internet connection in order
to avoid misuse by third parties via the internet. The entire data set was then burned to a
password protected CD and deleted from the computer. Data was maintained on the
secured, password protected CD for the duration of this research and will be further
maintained up to 5 years after its completion.
Summary
This quantitative, secondary data analysis study utilized a combination of
molecular and phenotypic lab techniques with statistical analysis and modeling to assess
the strength of various types of data (i.e., demographic, genotypic, phenotypic) for
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differentiating between HA- and CA-MRSA. Specifically, analysis of multiplex-PCR
data generated from 133 samples from MRSA patients attending the Johns Hopkins
Aramco Health Centre was used to assign HA-MRSA or CA-MRSA genotypic identity to
each sample. The genotypic information obtained from this exercise was used as the gold
standard to test the results obtained from database information on all of these samples by
applying the three phenotyping methods that could be used for MRSA identification.
These phenotyping methods were the health care risk factor, infection type (CDC, 2005)
and antibiotic susceptibility pattern methods (Clinical and Laboratory Standards Institute,
2005). Other predictive variables including age, gender, and survival status during MRSA
infection period (died/survived) and pre-existing illnesses were also tested. In this way, a
model was proposed for a combination of phenotypic variables that best predicts
genotyping results in terms of identification of MRSA as HA-MRSA and CA-MRSA.
After cross validation using new data, this model could then be used as a rapid, reliable,
and inexpensive test for MRSA status in the Saudi Aramco population in the Eastern
Province of Saudi Arabia.
The analyses I present in chapter 4 utilized John Hopkins Health Care Center
MRSA infection data, and MRSA multiplex PCR classification data to compute the
results of the statistical analyses used to answer the four research questions in detail.
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Chapter 4: Results
Introduction
The purpose of this quantitative, secondary data analysis study was to characterize
the MRSA strains within the Saudi Aramco community and to identify them accurately
as HA-MRSA or CA-MRSA by comparing and contrasting the three existing
phenotyping methods against the gold standard Multiplex PCR method. The three
existing phenotypic methods in question were the health care risk factor, infection type
(CDC, 2005) and antibiotic susceptibility pattern methods (Clinical and Laboratory
Standards Institute, 2005). Currently, the standard phenotyping method used in the Johns
Hopkins Saudi Aramco Health Centre, from which the samples for this study were
derived, is the health care risk factor method. However, individually each of the existing
phenotyping methods has been shown to have the potential for MRSA misclassification
(Sievert, 2008; Sievert et al., 2010). In addition, a discordance between methods used in
classifying MRSA as HA-MRSA or CA-MRSA has been observed (Sievert, 2008;
Sievert et al., 2010). For example, in studies conducted in Michigan, USA, while the
distribution of HA-MRSA versus CA-MRSA was similar for the health care risk factor
and infection type classifications, it was considerably different for the susceptibility
method.(Sievert, 2008; Sievert et al., 2010). There is also a variability in the
epidemiology of MRSA between countries (Maree et al., 2007; Pan et al., 2003 & 2005;
Labandeira-Rey et al., 2007; Song et al., 2011; Stefani et al., 2012; Tietz, Frei, &
Widmer, 2005).

97
While molecular methods of classification such as Multiplex PCR could be
considered the gold standard, these methods are expensive and resource intensive (Stefani
et al., 2012). Thus, previous literature suggested a need for a reliable, inexpensive, and
readily usable classification method to determine distribution of HA-MRSA and CAMRSA in the population under study. This classification method should either show the
concordance of existing phenotypic methods, or combine elements of the phenotyping
methods shown to be concordant, with the results of Multiplex PCR-based genotyping.
This need informed the above stated purpose of this study.
To achieve this purpose, I sought answers to the following four research questions:
•

Research Question 1: What is the genotypic distribution of MRSA in a subpopulation of Saudi Arabia’s Eastern Province?

•

Research Question 2: What is the concordance between each pair-wise
combination of the three phenotyping methods, health care risk factor, infection
type, and susceptibility pattern, used to classify CA- vs HA-MRSA in Saudi
Arabia?

•

Research Question 3: What is the sensitivity and specificity of each phenotyping
method (health care risk factor, infection type, susceptibility pattern) used to
classify CA-MRSA vs HA-MRSA in Saudi Arabia?

•

Research Question 4: How well does a combination of demographic and
phenotyping variables of the current three phenotyping methods (health care risk
factors, infection type, and susceptibility pattern) predict MRSA genotyping
classification as CA-MRSA or HA-MRSA?
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The null and alternative hypotheses associated with Research Question 4 were:
H0: Demographic and phenotyping variables do not significantly predict MRSA
genotyping classification.
Ha: Demographic and phenotyping variables significantly predict MRSA genotyping
classification.
In this chapter, I will describe the results of the statistical analyses used to answer
the four research questions in detail. In chapter 5, I will interpret and discuss these
results. Data collection and baseline descriptive and demographic characteristics of the
sample are reported, with consideration of the representativeness of the population
sample. The results are then described and organized by research questions/hypotheses. I
used tables and figures to illustrate results as appropriate. Finally, I summarized the
responses to the four research questions.
Data Collection
I obtained secondary data from all samples isolated between January 1, 2012 and
December 31, 2013 and stored in epidemiology and microbiology databases at the Johns
Hopkins Aramco Health Center. Data abstraction began after formal approvals from The
Saudi and Walden Institutional Review Boards. During the period between January 2012
and December 2013, the Johns Hopkins Aramco Health Center began collecting all
MRSA samples for validation of the multiplex PCR system. All isolated MRSA samples
were analyzed by this system for the PVL and mecA genes, using the method described
in Appendix A. Staphylococcus aureus infections were tested for sensitivity to the
following antibiotics: penicillin, oxacillin, gentamicin, ciprofloxacin, levofloxacin,

99
moxifloxacin, clindamycin, erythromycin, quinipristin, linezeloid, vancomycin, and
tetracyclin. Samples were defined as MRSA if the Staphylococcus. aureus strain was
found to be resistant to cefoxitin; it was assumed that they were also resistant to oxacillin.
However, 24 cases were excluded by the molecular biologists who analyzed the original
samples during data cleaning procedures, due to borderline resistance to oxacillin. Other
isolates with no definition of infection site and colonization were also excluded for the
original sample. This data cleaning process left 133 MRSA samples, which were used for
subsequent data analyses.
Baseline Characteristics of the Sample
The samples for this study were obtained from patients attending the Aramco
Dhahran Health Center (now the Johns Hopkins Aramco Health Center), a 405-bed,
acute-care hospital in Dharan, in the Eastern Province of Saudi Arabia. These patients are
a representative sample of the study population, i.e. approximately 350,000 people who
are employees, dependents or annuitants of the Saudi Aramco energy corporation
headquartered in Dhahran (Saudi Aramco, 2014). Most of the population are of Asian
origin, being either Saudis or nationals of other Arab or Asian nations. While those
included in the study represent a sub-population in the Eastern Province, the large size of
the population and their wide geographical distribution throughout the Eastern Province
makes them representative of the province as a whole.
The epidemiological data included the following independent variables: health
care risk factors, hospital admission profile, whether they had been hospitalized for at
least 48 hours prior to diagnosis or had been transferred from a different hospital,
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infection type, or bodily location of the infection, and antibiotic susceptibility profile.
They also included the covariates age, gender, survival status, and pre-existing illnesses.
A sample data line is shown in Table 4 of Chapter 3.
The descriptive statistics for the study sample are presented in Table 8.
Table 8
Descriptive Statistics of the Study Sample (N = 133)
Variable

Value

Frequency

Percent

Date

2012

49

36.8

2013

74

55.6

2014

14

7.5

Male

71

51.9

Female

66

48.1

Admission Profile

≥48 hours

53

39.8

Surgery

Yes

20

15

Catheterized

Yes

19

14.3

Dialysis

Yes

10

7.5

Hx_MRSA

Yes

23

17.3

Bacteremia

Yes

12

9

Pneumonia

Yes

28

21

Skin/Soft Tissue

Yes

40

30.1

Surgical/Deep Wound

Yes

53

39.8

Hospitalized

Yes

47

34.6

Clinic Visit past year

Yes

127

93.2

Survival

Yes

130

97.7

Comorbities

Yes

61

45.9

Drug Resistance

Beta lactams

133

100

Gender

continued
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Table 8 continued
Variable

Value

Frequency

Percent

Drug Resistance

Aminoglycoside

34

25.6

Cycline

42

31.6

CIP (Quinolone)

30

22.6

LEV (Quinolone)

27

20.3

MOXI (Q)

23

17.3

Macrolide

36

27.1

Nitrufuran

2

1.5

Quinolone

33

24.8

Sulfa

23

17.3

MRSA Health Care Risk

HA

72

54.1

Factors

CA

61

45.9

MRSA Infection Type Risk HA

96

69.2

Factors

CA

41

30.8

MRSA Susceptibility Risk

HA

64

48.1

Factors

CA

69

51.9

MRSA Genotyping

HA

63

47.4

CA

70

52.6

Results
The statistical analyses were carried out using SPSS® 21 statistical software
(IBM, 2012). The results will be divided into four sections, arranged according to
research question. Table 6 in Chapter 3 presented how each of the study variables was
used to answer the four research questions.
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Research Question 1
What is the genotypic distribution of MRSA in a sub-population of Saudi Arabia’s
Eastern Province?
The results of this analysis are summarized in Table 9.
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Table 9
Distribution of HA-MRSA and CA-MRSA as Defined by Genotyping using Multiplex PCR
(N = 133)
Variable

HA-MRSA

CA-MRSA

(N=63)

(N=70)

Male

41

28

Female

22

42

Age

Mean +/- SD

35.1 +/- 27.3

34.2 +/- 23.9

.839

Admission

≥ 48 hours

33

20

.005

< 48 hours

30

50

No

0

3

Yes

63

67

No

34

27

Yes

29

43

HA

42

30

CA

21

40

HA

48

44

CA

15

26

HA

49

15

CA

14

55

Gender

Profile

Survival

Pre-existing
illness
Health Care
risk factors
Infection type
risk factors
Susceptibility
pattern

Values

p Value

.004

.245

.075

.006

.096

<.001
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As Table 9 shows, there are observed statistically significant differences in the
distribution of the frequencies for all variables except “survival” and “infection type”
according to the type of MRSA classification. Of note, are the differences observed for
health care risk and susceptibility pattern. For these two phenotyping methods, the
frequency of HA and CA are statistically significant. Among the results for susceptibility
pattern phenotyping, 49 of 63 cases (77.78%) identified as HA by genotyping were HAMRSA by phenotyping as well, while 55 of 70 cases (78.57%) identified as CA by
genotyping were also CA-MRSA by phenotyping.
Mean age for those designated as HA-MRSA was 35.1 years versus 34.2 years for
CA-MRSA (Table 9). In Figure 3, I present the distribution of age for both HA-MRSA
and CA-MRSA.

Figure 3. HA-MRSA and CA-MRSA distribution by age.
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As suggested by the p Value associated with age in Table 9, there is not a
statistically significant difference between mean ages, though there are some minor
differences in the distributions. Among cases identified as HA-MRSA, the age
distribution is approximately bimodal with the highest frequencies observed under 20 and
over 40 years of age. For CA-MRSA, it is a single mode with the majority of cases
occurring between 20 and 40, and a defined positive skew.
Research Question 2
What is the concordance between each pair-wise combination of the three phenotyping
methods, health care risk factor, infection type, and susceptibility pattern, used to classify
CA- vs HA-MRSA in Saudi Arabia?
Concordance analysis for three phenotyping methods. I present a concordance
matrix in Table 10.
Table 10
Concordance Matrix (n = 51)
Health Care

Infection

Susceptibility

% Cases

Risk Factors

Type Risk

Risk Factors

matching

Factors
Concordant

HA

HA

HA

29 (22%)

CA

CA

CA

22 (16%)

In this table, I present the number and percentage of cases that were designated as
the same type of MRSA by the three phenotyping methods. Concordance or agreement
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on the designation of type of MRSA among all three methods for the designation of HAMRSA was 22%, while for the designation of CA-MRSA the overall concordance was
16%. Thus, all three methods agree on the designation of MRSA as HA or CA in less
than 25% of the cases. As the ideal situation is to have 100% concordance, this is very
low, though the statistical interpretation of this requires the use of Kendall’s tau, which is
the difference between the number of concordant pairs and the number of discordant
pairs divided by the total number of pair combinations (Newson, 2002). Like r, Kendall’s
tau varies between -1.0 (all pairs discordant) and +1.0 (all pairs are concordant). I discuss
this in more detail following my discussion of discordance.
In Table 11, I indicate in which of the three phenotyping methods the discordance
occurs, first for the designation of HA and then for the designation of CA.
Table 11
Discordance Matrix (n =86)
Health Care

Infection

Susceptibility

Number and

Risk Factors

Type Risk

Risk Factors

percent of cases

Factors
Discordant HA

Discordant CA

discordant

HA

HA

CA

31 (23%)

HA

CA

HA

9 (7%)

CA

HA

HA

15 (11%)

CA

CA

HA

17 (13%)

CA

HA

CA

11 (8%)

HA

CA

CA

3 (2%)
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In each of the three rows identified as “Discordant HA”, one of the three
phenotyping methods does not agree with the other two in the designation of HA-MRSA.
These are each associated with a percentage that indicates how frequently this type of
discordance occurred among the samples. Susceptibility was discordant with the other
two methods in 23% of the cases, while Infection Type was discordant in 7% of the
cases, and Health Care was discordant in 11% of the cases. Thus, susceptibility was the
most frequently discordant with the other two in designating HA-MRSA. I could find no
standard for discordance; my observation is a relative one suggesting that susceptibility
pattern produces a different distribution pattern than the other two phenotyping methods.
In each of the three rows identified as “Discordant CA”, one of the three
phenotyping methods does not agree with the other two in the designation of CA-MRSA.
These are each associated with a percentage that indicates how frequently this type of
discordance occurred among the samples. The desired discordance is 0%. Susceptibility
was discordant with the other two methods in 13% of the cases, while Infection Type was
discordant in 8% of the cases, and Health Care was discordant in 2% of the cases. Thus,
susceptibility was also the most frequently discordant with the other two in designating
CA-MRSA. Again, this is suggestive that susceptibility pattern produces a different
distribution pattern than the other two phenotyping methods.
To consider the magnitude of the concordance and discordance for each of the
pairs, I computed Kendall’s tau. As discussed previously, Kendall’s tau is the difference
between the number of concordant pairs and the number of discordant pairs divided by
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the total number of pair combinations (Newson, 2002). Kendall’s tau ranged from -.001
to .063, representing HA using susceptibility and CA using health care respectively. All
can be interpreted as no agreement between pairs.
Agreement. To further address this research question, I used Cohen’s kappa (κ).
Cohen's kappa (κ) can range from -1 to +1. Based on the guidelines from Altman (1999),
and adapted from Landis & Koch (1977), a kappa (κ) of negative means none, 0-.20 is
slight, 0.21-0.40 is fair, 0.41-0.60 is moderate, 0.61-0.80 is substantial, and 0.81-1 is
almost perfect agreement. The value for kappa and the associated p value for each
combination are presented in Table 12. The value for all three phenotyping measures and
the genotype is presented in Table 13. Pairwise Cohen’s kappa= 0.317, p < .001
suggesting fair agreement was obtained for health care risk and infection type methods.
Similarly, Cohen’s kappa= 0.101, p = 243 suggesting slight agreement, was obtained for
comparison of the susceptibility pattern and health care risk methods. Finally Cohen’s
kappa= -0.008, p = .919, suggesting no agreement, was obtained for comparison of the
susceptibility pattern and infection type methods (Table 12). The results of the
comparison of the three phenotyping methods to the genotyping method in terms of either
HA-MRSA or CA-MRSA individually gave Cohen’s kappa= 0.373, p <.001 for both
HA-MRSA and CA-MRSA, with an overall agreement with Cohen’s kappa= -0.298, p
<.001. (Table 13). These measures are all suggestive of fair agreement with the
genotyping method.
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Table 12
Pairwise Agreement Between Phenotyping Methods (n = 133)
Methods compared

Percent

Cohen’s kappa

p Value

Health Care Risk and Infection Type 66.9

.317

<.001

Health Care Risk and Susceptibility

54.9

.101

.243

Infection Type and Susceptibility

48.9

-.008

.919

pairwise
agreement

Table 13
Agreement Between 3 Phenotyping Methods and Genotyping Measured by Cohen’s
kappa (n = 133)
Category

Cohen’s kappa

p Value

HA_MRSA

.373

<.001

CA_MRSA

.373

<.001

Overall Agreement

-.298

<.001

Research Question 3
What is the sensitivity and specificity of each phenotyping method (health care risk
factor, infection type, susceptibility pattern) used to classify CA-MRSA vs HA-MRSA in
Saudi Arabia?
Sensitivity and specificity of phenotyping methods. The results of the
sensitivity and specificity measurements for each phenotyping method are shown in
Tables 14, 15, and 16 for health care risk factor, infection type, and susceptibility pattern
respectively. I will interpret the results of the evaluation of sensitivity and specificity of
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the phenotyping methods in chapter 5 to determine the appropriateness of each of the
three phenotyping approaches as a screening tool. In this context, however, sensitivity
represents the ability to identify the case as HA if it is indeed HA per the gold standard,
while specificity is the ability to identify cases as CA if they are CA. Since true results
are desired for cases designated as either HA or CA, in this study, I am looking for
methods with both a high sensitivity and a high specificity. FDA approved techniques
usually yield 82 to 100 percent sensitivity and 64 to 99 specificity (Marlowe &
Bankowski, 2011).
Table 14
Sensitivity and Specificity of Health Care Risk Factors Phenotyping Method
MRSA (genotyping)
Phenotyping (Health

HA

CA

HA

True HA = 42

False HA = 30

CA

False CA = 21

True CA= 40

Sensitivity = 0.6667

Specificity = 0.5714

Care risk method)
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Table 15
Sensitivity and Specificity of Infection Type Phenotyping Method
Phenotyping

MRSA (genotyping)

(Infection type
method)
HA

CA

HA

True HA = 48

False HA/CA = 44

CA

False CA/HA = 15

True CA = 26

Sensitivity = 0.7619

Specificity = 0.3715

Table 16
Sensitivity and Specificity of Susceptibility Pattern Phenotyping Method
Phenotyping

MRSA (genotyping)

(Susceptibility
Pattern method)
HA

CA

HA

True HA = 49

False HA/CA = 15

CA

False CA/HA = 14

True CA = 55

Sensitivity = 0.7778

Specificity = 0.7857

A comparison of the sensitivity and specificity as well as associated 95%
confidence intervals is presented in Table 17.
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Table 17
Comparison of Phenotyping Methods as Measured Against Genotyping Results
MRSA strain Phenotyping
method

Proportion

95% Confidence intervals

correctly
identified

HA-MRSA

CA-MRSA

HRSA

0.6667

0.5866

0.7468

IFRF

0.7619

0.6885

0.8343

Susceptibility

0.7778

0.7071

0.8485

HRSA

0.5714

0.4873

0.6555

IFRF

0.3714

0.2893

0.4534

Susceptibility

0.7857

0.7160

0.8554

As discussed with Tables 14, 15, and 16, my goal in response to Research
Question 3 is to identify the phenotyping method that is most successful in identifying
true HA and CA cases. The results presented in Table 17 suggest that among the
phenotyping methods, only susceptibility has a sensitivity and specificity similar to the
ranges accepted by the FDA ((Marlowe & Bankowski, 2011).
In Figure 4, I present a bar graph, which graphically demonstrates the percentage
of HA-MRSA and CA-MRSA correctly identified for each phenotyping method when
they are compared to the genotyping method.
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78%

76%

79%

HA_MRSA

CA_MRSA

67%
57%

32%

Healthcare

Infection Type

Susceptibility

Figure 4. HA-MRSA and CA-MRSA correct identifications by three phenotyping
methods.
ROC curve. In Figure 5, I present an ROC curve of the ability of the three
phenotyping methods to identify correctly the infection as CA-MRSA. The ROC curve
provides a visible image of the sensitivity and specificity of screening tools. The
reference is the point where sensitivity and specificity are equal. The lines to the left of
the reference line have higher sensitivity than specificity, while those to the right have
higher specificity than sensitivity. The lines representing each of the three phenotyping
methods can be compared to see which one is most appropriate to use for screening.
While all phenotyping methods have higher ability to identify HA-MRSA than CAMRSA correctly, the Infection type is less likely and the Susceptibility is more likely to
identify both HA-MRSA and CA-MRSA correctly.
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Figure 5. ROC curve comparing phenotyping methods on their ability to identify CAMRSA.
Research Question 4
How well does a combination of demographic and phenotyping variables of the current
three phenotyping methods (health care risk factors, infection type, and susceptibility
pattern) predict MRSA genotyping classification as CA-MRSA or HA-MRSA?
H0: Demographic and phenotyping variables do not significantly predict MRSA
genotyping classification.
Ha: Demographic and phenotyping variables significantly predict MRSA genotyping
classification.
To answer this research question, I performed multiple logistic regression using
block entry to determine the best model after checking the assumptions required were
met. I first determined that the dependent variable was binomial, the independent were
continuous or nominal, and that the observations were independent. Using SPSS, I then
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determined there was a linear relationship between the dependent and independent
variables without multicollinearity or extreme outliers.
In Table 18, I present the blocks of variables that were included for multiple
logistic regression.
Table 18
Variables Entered in Each Block for Multiple Logistic Regression
Block

Independent variable(s)

1

Health Care Risk Factors

2

Infection Type Risk Factors

3

Antibiotic Susceptibility: Ciprofloxacin, Clindamycin,
Gentamicin, Levofloxacin
Trimeth-Sulfamethoxazole

4

Demographics: Age, hospital admission profile, preexisting illness

Full model using block entry. In Table 19, I present the results of the full model
determined using block entry multivariate binary logistic regression. This regression
yielded the combination of phenotype variables that best predicted the genotype as
defined by multiplex PCR, and therefore CA/HA status.
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Table 19
Odds Ratios Computed Using Multivariate Binary Logistic Regression with Block Entry
Step

Variable

B

EXP(B)

95% Confidence Interval
Lower

Upper

Block 1

MRSA_HCRF

.100

1.105

.310

3.836

Block 2

MRSA_IFRF

.488

1.630

.542

4.898

Block 3

MRSA_Susceptibility

2.739 15.474

5.995

39.938

Block 4

Gender

.549

1.731

.230

1.450

Admission Profile

1.056 2.874

.764

10.815

Pre-existing Illness

.149

.460

2.932

1.161

In Table 19, the lowest OR (EXP (B)) is associated with the first block, which has
the health care risk factors phenotyping methods. In contrast, Block 3, which adds the
susceptibility phenotyping method, is associated with the highest OR. After adding all the
blocks, only susceptibility was found statistically significant, though the OR associated
with Admission Profile suggests it may be statistically significant in a reduced model.
These results suggest that susceptibility phenotyping is most effective in determining
whether MRSA is HA or CA without having to use genotyping methods.
The Cox & Snell and the Negellkerke R Squares comparing the strength of each
block included in the multivariate models described above are presented in Table 20.
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Table 20
Pseudo R Square Associated with Each Block
Step

Cox & Snell R Square

Nagelkerke R Square

Block 1

.056

.075

Block 2

.061

.081

Block 3

.330

.440

Block 4

.348

.464

Among the Pseudo R Square values presented in Table 20, the largest change
occurred after the addition of block three. Using the Cox & Snell R Square, this change
was .269, while using Nagelkerke, it was .359. These pseudo R squares can be used to
determine which model fits the data best in terms of explaining the variance associated
with the dependent variable. While these Pseudo R Square values cannot be interpreted as
the percent of the variance explained by the model as a true R square can, they do
indicate the relative improvement in the predictive ability associated with the addition of
a block. The addition of Block 3 caused the greatest improvement in predictability. There
was little improvement associated with Block 4.
In Table 21, I present the results of the Hosmer and Lemeshow Test of Model Fit
after the entry of each of blocks 2 through 4.
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Table 21
Hosmer and Lemeshow Test of Model Fit
Step

Chi square

Degrees of

Significance

freedom
Block 2

5.597

2

.061

Block 3

4.765

5

.445

Block 4

3.688

7

.815

In Table 21, chi square was used to compare the results expected based on the
model to those actually observed. The magnitude and significance of the chi square are
used to estimate the model fit. Models with lower magnitude and a p value greater than
.05 exhibit a better fit than those with greater magnitude and statistically significant
differences (Newman, 2001). The model with all four blocks has the best fit, though the
model with block 3 is also not statistically significant indicating an acceptable fit.
A scatter plot of the change in deviance by the predicted probability for the full
model is presented in figure 6.
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Figure 6. Scatter plot of the change in deviance and predictive probabilities for the full
model.
The curve that extends from the lower left to the upper right represents the cases
in which the dependent variable was assigned a value of 0. This corresponds to the
genotyping designation of HA-MRSA. The curve that extends from the lower right to the
upper left represents the cases in which the dependent value was assigned a value of 1.
This corresponds to the designation of cases as CA-MRSA. The quadratic like curves of
the plots are similar. Each of the scatter dots represents a case, with those that do not fit
the logistic regression model, also known as outliers, in the top left or top right corners of
the plots. There are nine cases identified as HA-MRSA and eight identified as CA-MRSA
with a change in deviance greater than one.
Reduced model. A reduced model was also produced using the backwards
conditional method. I also created a multivariate binary logistic regression model using
the backward conditional method to yield the combination of variables that best predicts
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genotype, and therefore CA/HA status. I present the results in Table 24. This second
approach was used to confirm the assignment of odds ratios in the block entry model. In
each step 1-5, variables were removed from the original full model to yield the final
reduced model. The susceptibility pattern method (MRSA_Susceptibility) had an EXP
(B) of 15.549 (95% CI 6.292-38.424) and admission profile had an EXP (B) of 3.942
(95% CI 1.568-9.911).
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Table 22
Odds Ratios of Variables included in the Reduced Models at Each Step
Step

Variable

B

EXP(B)

95% Confidence interval
Lower

1

2

3

4

5

Upper

MRSA_HCRF

.100

1.105

.310

3.836

MRSA_IFRF

.488

1.630

.542

4.898

MRSA_Susceptibility

2.739 15.474

5.995

39.938

Gender

.549

1.731

.230

1.450

Admission Profile

1.056 2.874

.764

10.815

Pre-existing Illness

.149

1.161

.460

2.932

MRSA_IFRF

.486

1.625

.541

4.879

MRSA_Susceptibility

2.740 15.480

5.997

39.959

Gender

.570

.734

4.258

Admission Profile

1.124 3.076

1.125

8.409

Pre-existing Illness

.148

1.159

.458

2.931

MRSA_IFRF

.436

1.546

.539

4.440

MRSA_Susceptibility

2.708 15.005

5.995

37.783

Gender

.576

.740

4.274

Admission Profile

1.113 3.004

1.116

9.069

MRSA_Susceptibility

2.671 14.460

5.813

35.975

Gender

.615

.775

4.415

Admission Profile

1.268 3.555

1.394

9.069

MRSA_Susceptibility

2.744 15.549

6.292

38.424

Admission Profile

1.372 3.942

1.568

9.911

1.768

1.778

1.850

The ORs (EXP(B)) presented in this table demonstrate to what extent each of the
independent variables are associated with the dependent variable. Note that the ORs and
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their associated CI change with each iteration. These changes reflect the effect the
removal of some of the independent variables from the model have on the observed
associations. The magnitude of the OR reflects the direction and strength of the
associations, while the lower and upper bounds of the CI suggest the significance.
Susceptibility was found to be a statistically significant predictor of MRSA status in all
models. This is in agreement with the conclusions drawn from the full model. Unlike the
full model, however, Admission profile became significant only after the removal of Preexisting illness. The final model (5) is the most parsimonious and the only one in which
both independent variables have statistically significant ORs. I examined the changes in
the predictive ability of the independent variables included in the model using Cox &
Snell and Negelkerke R Squares. I also tested if this model can be applied to this
population in the future to quickly and cheaply assess the HA/CA status of a new MRSA
case without requiring the time-consuming and expensive procedure of genotyping, using
the Hosmer and Lemeshow test to evaluate the final model fit after each step in the
iterative process.
The results of the comparison of the Cox & Snell and Negelkerke R Squares
calculated with each model iteration using the backwards conditional method are
presented in Table 23. These values suggest that there is little difference in the models
ability to predict HA or CA-MRSA. Though the R square associated with Model 5 is
lower it is not low enough to justify including variables in the model which do not have
statistically significant ORs, such as those included in models 3 and 4.
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Table 23
Pseudo R Square Associated with Each Block
Step

Cox & Snell R Square

Nagelkerke R Square

1

.348

.464

2

.347

.464

3

.347

.463

4

.344

.459

5

.334

.446

Table 24 presents the results of the Hosmer and Lemeshow Test of Model Fit
after the entry of each of steps 1 through 5. As with Table 21, these numbers reflect each
model’s ability to explain the variability of the logit associated with the designation of
HA or CA-MRSA.
Table 24
Hosmer and Lemeshow Test of Model Fit
Step

Chi square

Degrees of

Significance

freedom
1

3.688

7

.815

2

2.836

8

.944

3

2.967

8

.936

4

2.119

6

.908

5

.807

2

.668

The chi square statistic describes the model fit by comparing the expected
outcomes based on the model inputs to the actual assignment of HA and CA-MRSA

124
using genotyping. All models are not statistically significant suggesting they fit the data.
The models with more than two variables have higher chi square, but again the
differences observed do not justify including non-significant independent variables in the
model.
A scatter plot of the change in deviance by the predicted probability for the
reduced model is presented in Figure 7.

Figure 7. Scatter plot of the change in deviance and predictive probabilities in the
reduced model
As with figure 6, the scatter plot of the change in deviance allowed me to identify
cases that poorly fit by the model. These are considered outliers. Larger changes in
deviance indicate poorer fits. The curve that extends from the lower left to the upper right
represents the cases in which the dependent variable was assigned a value of 0. This
corresponds to the genotyping designation of HA-MRSA. The curve that extends from

125
the lower right to the upper left represents the cases in which the dependent value was
assigned a value of 1. This corresponds to the designation of cases as CA-MRSA. In this
plot there are four outliers, two associated with the designation of HA-MRSA and two
with the designation of CA-MRSA. Were there more outliers, further investigation might
be warranted, but the existence of four outliers, two in each direction, in a dataset with
133 records is unlikely to have an effect on my conclusions (Newman, 2001).
Finally, the comparison of the results of the final full model to the final reduced
model is presented in Table 25.
Table 25
Comparison of Full and Reduced Models
Model

Included variables

Odds ratios

Nagelkerke

Hosmer and

(p Value)

R Square

Lemeshow
test results (p
Value)

Full

MRSA_HCRF

1.105 (.878)

MRSA_IFRF

1.630 (.542)

MRSA_Susceptibility

15.474 (<.001)

Gender

1.731 (.242)

Admission Profile

2.874 (.008)

Pre-existing Illness

1.161 (.861)

Reduced MRSA_Susceptibility
Admission Profile

15.549 (<.001)

.464

3.688 (.815)

.446

.807 (.668)

3.942 (.004)

As demonstrated in Table 25, the full and the reduced models both suggest the
same model may be most effective in accurately predicting HA and CA designations
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based on genotyping using Multiplex PCR. Both the full and the reduced models confirm
my previous conclusions that Susceptibility is the phenotyping method of choice. In both
models, Susceptibility (OR~15.5, p <.001) is a significant predictor of HA or CA-MRSA,
though in the full model it is the only statistically significant predictor, while in the
reduced model Admission Profile (OR 3.94 p=.004) was statistically significant as well.
In both models, the Nagelkerke R square is similar and suggests an acceptable degree of
predictability. Finally, while the chi square is much higher in the full model, after
adjustment for the degrees of freedom, those values are also similar. In the absence of
significant differences in model fit and predictability, the reduced model is preferable as
it requires fewer variables and therefore less data to complete.
Based on the results of the multiple logistic regression, I am able to reject the null
hypothesis in favor of the alternative one associated with this research question.
Demographic (Admission profile) and phenotyping (Susceptibility pattern) significantly
predict MRSA genotyping classification.
Summary
Through the process of this study a verified MRSA phenotyping method
supported by a genotyping ‘gold standard’ classification method for MRSA strains
isolated in the Saudi Aramco community in the Eastern province of Saudi Arabia was
established. Three commonly used phenotyping methods, health care risk factors,
infection type (CDC, 2005), and susceptibility pattern (Clinical Laboratory Standards
Institute (Clinical and Laboratory Standards Institute, 2005) were used to classify the
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MRSA strains into CA-MRSA or HA-MRSA. I present a summary of my findings for
Research Questions 1, 2, 3, and 4 in Table 26.
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Table 26
Summary of Findings Research Questions 1, 2, 3, and 4
Research question
What is the genotypic distribution of
MRSA in a sub-population of Saudi
Arabia’s Eastern Province?

What is the concordance between each
pair-wise combination of the three
phenotyping methods, health care risk
factor, infection type, and susceptibility
pattern, used to classify HA or CAMRSA in Saudi Arabia?

Statistical results
Health Care Risk Factor
HA = 66.67% correct
CA = 57.14% correct
Infection Type
HA = 76.19% correct
CA = 37.14% correct
Susceptibility Pattern
HA = 77.78% correct
CA = 78.57% correct
Concordance = 22%

Kendall’s tau -.001 to .063

Conclusions
Susceptibility pattern phenotyping had the
highest percent of correct designations
when compared to genotyping.

While the observed concordance between
pairs based on percent concordant and
Kendall’s tau suggest little to no agreement
between phenotyping methods, Cohen’s
kappa suggests fair agreement between
phenotyping and genotyping.

Cohen’s kappa = .373 p<.001 HA and
CA-MRSA and -.298 p < .001 overall
continued
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Table 26 continued
Research question
What is the sensitivity and specificity of
each phenotyping method (health care
risk factor, infection type, susceptibility
pattern) used to classify CA-MRSA vs
HA-MRSA in Saudi Arabia?

Statistical results
Health Care Risk Factor
HA = 66.67% (sensitivity)
CA = 57.14% (specificity)
Infection Type
HA = 76.19% (sensitivity)
CA = 37.14% (specificity)
Susceptibility Pattern
HA = 77.78% (sensitivity)
CA = 78.57% (specificity)
How well does a combination of
Full Model
demographic and phenotyping variables OR Susceptibility = 15.474 (p<.001)
of the current three phenotyping
Nagelkerke R Square = .464
methods (health care risk factors,
Hosmer and Lemeshow = 3.688 (p =
infection type, and susceptibility pattern) .815)
predict MRSA genotyping classification
as CA-MRSA or HA-MRSA?
Reduced Model
OR Susceptibility = 15.549 (p<.001)
OR Admission Profile = 3.942 ( = .004)
Nagelkerke R Square = .446
Hosmer and Lemeshow = .807 (p =
.668)

Conclusions
The calculation of sensitivity and specificity
confirms the conclusions drawn in response
to RQ 1. That is, Susceptibility has the
highest sensitivity (ability to correctly
predict HA) and the highest specificity
(ability to correctly predict CA)

While both the full and reduced model were
predictive of HA and CA-MRSA
classification using genotyping and had a
reasonably good fit, only in the reduced
model was the OR associated with
Admission Profile significant. The reduced
model also has the advantage of requiring
only two variables and thus increased ease
of use.
Based on both model results, I am able to
reject the null hypothesis associated with
this RQ.
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As suggested in this table, all of my findings associated with the four research
questions suggest that it is possible to predict the designation of HA or CA-MRSA
resulting from genotyping using Susceptibility Pattern phenotyping. In the reduced
multiple logistic regression model, I also identified Admission Profile as a significant
predictor of genotyping results.
In Chapter 5, I summarize, analyze, and interpret key findings from these results
and discuss whether they confirm, disconfirm, or extend existing knowledge per the
literature review and the Ecological Theory that was the framework for this study. I also
acknowledge and discuss the limitations of the study in terms of generalizability and/or
trustworthiness, validity, and reliability. Recommendations for further research grounded
in the strengths and limitations of the study and the literature reviewed in chapter 2 will
be suggested, specifically as related to MRSA testing in Saudi Arabia within the Saudi
Aramco community. In this context, implications for positive social change and
recommendations for practice will be discussed, along with methodological, theoretical,
and/or empirical implications. Finally, conclusions will be drawn to capture the key
essence of the study.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this quantitative, retrospective cohort study was to characterize the
MRSA strains within the Saudi Aramco community and to classify them accurately as
HA-MRSA or CA-MRSA by comparing and contrasting the three existing phenotyping
methods against the gold standard Multiplex PCR method. My goal was to identify the
phenotyping method with the highest sensitivity and specificity for use in this population.
Thus, this research will contribute to identify a simple, less expensive, accurate, and
feasible method for full MRSA assessment in Saudi Arabia.
In this chapter, I summarize, interpret, and discuss key research findings. My
conclusions were drawn in the context of previous research and the theory that framed
this research. In addition, I include recommendations for the application of the study
findings and future research. Finally, I discuss the impact of my study results and its
potential implications for positive social change.
Research Questions
The research questions I formed to address the purpose of my research were the
following:
•

Research question 1: What is the genotypic distribution of MRSA in a subpopulation of Saudi Arabia’s Eastern Province?

•

Research Question 2: What is the concordance between each pair-wise
combination of the three phenotyping methods, health care risk factor, infection
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type, and susceptibility pattern, used to classify CA- vs HA-MRSA in Saudi
Arabia?
•

Research Question 3: What is the sensitivity and specificity of each phenotyping
method (health care risk factors, infection type, and susceptibility pattern) used to
classify CA-MRSA vs HA-MRSA in Saudi Arabia?

•

Research Question 4: How well does a combination of demographic and
phenotyping variables of the current three phenotyping methods (health care risk
factors, infection type, and susceptibility pattern) predict MRSA genotyping
classification as CA-MRSA or HA-MRSA?
H0: Demographic and phenotyping variables do not significantly predict
MRSA genotyping classification.
Ha: Demographic and phenotyping variables significantly predict MRSA
genotyping classification.
Summary of Key Findings
The key findings from the study can be concisely summarized with respect to

individual research questions. For Research Question 1, the key finding was that of the
three phenotyping methods, the susceptibility pattern phenotyping method most closely
resembled that obtained using the genotyping gold standard. For Research Question 2, the
concordance analysis indicated that the susceptibility pattern method was the most
discordant of the three phenotyping methods tested. For Research Question 3, the
susceptibility pattern method emerged as the most sensitive and specific of the three
phenotyping methods. Lastly, for Research Question 4, a reduced model comprising the

133
combination of susceptibility pattern phenotyping with hospital admission profile
emerged as the most effective combination of the variables tested to accurately predict
HA-MRSA and CA-MRSA, as defined by the genotyping gold standard. In the remainder
of this section, these findings are interpreted and discussed in detail.
Interpretation and Discussion of Key Findings
The statistical analysis in response to Research Question 1 produced the
distribution of HA-MRSA and CA-MRSA, as defined by the gold standard multiplex
PCR genotyping method, by gender, age, hospital admission profile, survival, preexisting illness and the three phenotyping methods, health care risk factors, infection type
and susceptibility pattern. The distributions are presented in Table 9. Differences, though
not tested for statistical significance, were observed in the distributions of all but the
survival variable. The findings related to the three phenotyping methods are key to this
research, as I am attempting to identify the phenotyping variables which best predict the
MRSA profile obtained by genotyping. While the MRSA distribution with regards to
each of the three phenotyping method variables was similar for HA-MRSA, the
susceptibility pattern data differed from the other two variables for CA-MRSA. Only
using the susceptibility pattern did I find a distribution similar to that expected based on
the gold standard genotyping, with the majority of cases correctly identified as either HAMRSA or CA-MRSA according to the comparison to the genotyping data. Neither the
health care risk factors method nor the infection type method gave a distribution similar
to the genotyping method. This has implications for any use of these methods for
classification of MRSA in a Saudi Arabia health facility context, in particular for
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designation as CA-MRSA. Genotyping methods based on DNA analysis allow for
accurate and precise MRSA classification, due to markers that are less prone to change
over time (Tenover et al., 1994). A recent genotyping study in Saudi Arabia has found
that HA-MRSA resistance markers (e.g., aacA-aphD, aadD) are now common among
CA-MRSA strains (Monecke et al., 2012). It would be expected that presence of these
resistance markers in both HA and CA-MRSA would negatively impact on the accuracy
of the susceptibility pattern method. Nevertheless, in this case the susceptibility pattern
method emerged as the most similar to the genotyping method in the predicted
distribution of CA-MRSA and HA-MRSA.
Worldwide experience of the spread of CA-MRSA into health care settings and
the emergence of HA-MRSA in the community has challenged assignment of MRSA
purely in terms of the health care risk and infection type phenotyping methods
(Campanile et al., 2011; David et al, 2008a; Donnio et al., 2004; Hetem et al., 2012;
Maree et al., 2007; Nair et al., 2011; Otter & French, 2011; Song et al., 2011). The results
in response to Research Question 1 in my study extend this pattern in that neither of these
phenotyping methods give results consistent with those generated by genotyping. In a
study conducted at Chicago hospitals, many MRSA infections in patients with health care
risk factors had many features of CA-MRSA, including clindamycin-resistance, PVL
positivity, and SCCmec IV (David et al., 2008a). Similarly, in the genotyping study
carried out at King Fahad Medical City in Riyadh, there was a high prevalence of PVLexpressing strains, normally considered to be an indicator of CA-MRSA, in the health
care setting (Monecke et al., 2012). The effect of the increasing unreliability of health
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care risk factors as a predictor of HA-MRSA versus CA-MRSA is that CA-MRSA
prevalence is underestimated. The health care risk factors and infection type methods
have a higher tendency to identify HA-MRSA than the susceptibility pattern or
genotyping methods (Sievert 2008). This is borne out in my results in response to
Research Question 1, in which use of the infection type method actually resulted in the
majority of CA-MRSA cases being identified as HA. One of the challenges to the
infection type method comes from confirmation that skin and soft tissue infections (SSTI)
are the most common types of infections for both CA-MRSA and HA-MRSA (David et
al., 2008a). Meanwhile for the health care risk factors method, 30 out of 70 of those
designated as CA-MRSA by genotyping were identified as HA by phenotyping. Several
studies have shown that phenotyping markers are more prone to change over time than
genotyping markers (Devita, Lawrence, & Rosenberg, 2009). Such a change is due to
loss of extrachromosomal genetic elements and later their horizontal transmission (Devita
et al., 2009) and can explain the discrepancy between the classification methods that
depend on the phenotyping markers (Tenover et al., 1994). This discrepancy was more
closely considered in Research Question 2.
Also notable in my analysis of the data for Research Question 1 was the
difference in the distributions of age for HA-MRSA versus CA-MRSA as designated by
genotyping, presented in Figure 3. Among cases identified as HA-MRSA, the age
distribution is approximately bimodal with the highest frequencies observed under 20 and
over 40 years of age (Figure 3). By contrast, for CA-MRSA, it is a single mode with the
majority of cases occurring between 20 and 40, and a defined positive skew (Figure 3).
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This type of distribution is largely consistent with the results of others, for example in the
study by Huang et al. (2006) in California, in which CA-MRSA was most prevalent in
those aged between 18 to 49 and HA-MRSA among those aged from 40 years up (Huang
et al., 2006). In a study undertaken in Riyadh, Saudi Arabia, the most prevalent HAMRSA strain identified, CC8/ST239-III, was also found more commonly in older than
average patients, with a mean age of 43 years (Monecke et al., 2012).
My results on distribution of HA-MRSA and CA-MRSA with respect to
genotyping data are consistent with studies of others on phenotyping and genotyping
concordance, which suggested that antibiotic susceptibility pattern (Clinical Laboratory
Standards Institute (CLSI), 2005) may be particularly helpful in classification, especially
given the increasingly questioned predictability of health care risk. (Campanile et al.,
2011; David et al, 2008a; Donnio et al, 2004; Hetem et al., 2012; Maree et al., 2007; Nair
et al., 2011; Otter & French, 2011; Song et al., 2011). I considered concordance
specifically in response to Research Question 2.
In Research Question 2, I further explored the issue of agreement or disagreement
between the phenotyping methods, using a concordance and a discordance matrix. These
matrices are presented in Tables 14 and 15 respectively. As described in Chapter 4, the
results of the concordance analysis indicated that the susceptibility pattern method gives a
different classification profile compared to the other two methods, being the most
discordant of the three methods. This is compatible with the findings generated in
response to Research Question 1, which indicated that the susceptibility pattern method
gives a distribution that is closer than the other two phenotyping methods to that obtained
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by genotyping. It is also consistent with the results of a study conducted at the Michigan
Department of Community Health in the United States, which showed that the health care
risk factors and infection type methods were more concordant with each other than either
are with the susceptibility pattern method (Sievert et al., 2010). Each of the three
classification methods is inconsistent with the other two, for a number of cases. One
important reason that contributes to discordance between methods is the evolving and
increased rate of invasive CA-MRSA strains (Seybold et al., 2006). Emergence of the
health-care-associated community-onset (HACO) group due to the interchange of genetic
lineages of MRSA among community and hospital niches, and the evolution of multi
drug resistant CA-MRSA strains which can invade hospitals, also affects the distribution
of MRSA clones (David et al., 2006; Hudson et al., 2013).
When agreement between methods was formally tested by pairwise Cohen’s
kappa analysis, presented in Tables 16 and 17, the results confirmed that there was higher
agreement between the health care risk and infection type methods than between either of
those and the susceptibility pattern method. My Cohen’s kappa data confirms that the
susceptibility pattern method diverges from the other two methods and that as a result,
overall agreement between the three methods is low. The susceptibility pattern method
may be divergent from the other two methods either because the rate of multidrug
resistant CA-MRSA is significantly increased within the Johns Hopkins Saudi Aramco
Health Centre compared to the rate of invasive CA-MRSA, or due to the emergence of
invasive CA-MRSA as a nosocomial infection (Hudson et al., 2013). This would be
isolated after 48 hours from deep sites, giving it the characteristics of HA-MRSA and
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explaining the ‘false’ higher concordance between the health care risk factors method and
infection type method. This discordance of the susceptibility pattern method was
consistent with what I expected given my results from Research Question 1, in which of
the three phenotyping methods only the susceptibility pattern yielded a MRSA
distribution pattern similar to that observed for the genotyping method, and the results of
others also suggesting that the health care risk factors and infection type methods are
more concordant with each other than either are with the susceptibility pattern method
(Sievert et al., 2010). My results are also consistent with other studies showing
concordance between antibiotic susceptibility phenotyping and genotyping and/or poor
predictability of the health care risk factors method (Campanile et al., 2011; David et al,
2008a.; Donnio et al, 2004; Hetem et al., 2012; Maree et al., 2007; Nair et al., 2011; Otter
& French, 2011; Song et al., 2011). In a study where genotype of MRSA was predicted
using a fluoroquinolone susceptibility test, the results of antibiogram and PFGE were
significantly correlated (Chomvarin et al., 2005). Concordance between the Gene Xpert
multiplex PCR genotyping method and phenotyping by antibiotic susceptibility using the
disk diffusion method has also been shown (Biendo et al., 2013). My results also indicate
concordance between the susceptibility pattern phenotyping methods and genotyping as
carried out by multiplex PCR.
In response to Research Question 3, I considered the sensitivity and specificity of
each of the three phenotyping methods. Generally speaking, less invasive screening tools
need to have higher sensitivity, i.e. the ability to identify all potential cases. In the context
of my study, however, sensitivity represents the ability to correctly identify a MRSA case
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as HA-MRSA using a given phenotyping method, if it is indeed HA-MRSA as defined
per the genotyping gold standard. Specificity, meanwhile, is the ability to correctly
identify a MRSA case as CA-MRSA using a given phenotyping method, if they are
indeed CA-MRSA as defined by the genotyping gold standard. Since the goal of my
study was to identify a phenotyping method that could be used to accurately classify
MRSA cases as HA-MRSA or CA-MRSA, I am looking for methods that have both a
high sensitivity and a high specificity.
My tests of the sensitivity and specificity of the three phenotyping methods in
response to Research Question 3 indicated that all three phenotyping methods had similar
ability to identify HA-MRSA Using the infection type method, however, made it
significantly less likely than for the other two that CA-MRSA would be identified
correctly. This is compatible with the results of Research Question 1, in which only 26
out of 70 (37.14%) cases identified as CA-MRSA by genotyping were designated CAMRSA by infection type phenotyping. I found that the susceptibility pattern method is,
by contrast, significantly more likely to correctly identify CA-MRSA, compared to the
health care risk method sensitivity. This is what I would have expected given the data
from Research Question 1, showing that 55 out of 70 (78.57%) cases designated as CAMRSA by genotyping were also designated as CA by susceptibility pattern phenotyping.
It is also consistent with the concordance data from Research Question 2, suggesting that
the susceptibility pattern method differs significantly from the other two methods in its
ability to classify either HA or CA correctly per the gold standard. Thus, the results from
Research Question 3 added another element to the emerging consensus that the
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susceptibility pattern method is the most effective of the three phenotyping methods in
the context of this study, as it has higher specificity and is therefore less likely to
misclassify CA-MRSA cases. This finding suggests that the rate of multidrug resistant
CA-MRSA is low, however the rate of invasive CA-MRSA is increased within the Johns
Hopkins Saudi Aramco Health Centre population, impacting negatively on the health care
risk factors method and the infection type method sensitivity and specificity. Currently,
the most commonly used phenotyping method used in Saudi Arabia for MRSA
classification is the health care risk factors method. However, the selection of
phenotyping method to classify MRSA and guide infection control depends on methods
validated for the USA hospitals (Bukharie, 2010). This is despite the fact that prevalence
and incidence of HA-MRSA versus CA-MRSA varies widely between countries (Maree
et al., 2007; Pan et al, 2003 & 2005; Labandeira-Rey et al., 2007; Song et al., 2011;
Stefani et al., 2011; Tietz, Frei, & Widmer, 2005). Consistent with international
experience, previous studies in Saudi Arabia have shown that prevalence of CA-MRSA is
increasing, while the lines between ‘HA-MRSA’ and ‘CA-MRSA’ are blurring in terms
of health care risk factors (Al‐Tawfiq, 2006; Baddour et al., 2007; Bukharie, 2010; David
et al., 2008; Monecke et al; 2102; Moussa & Shibl, 2009; Stefani et al;, 2012). All these
factors suggest that the health care risk method is not the most ‘fit for purpose’ in the
Saudi Arabian context; my results add to the evidence that this is the case. The results
generated in my study in response to Research Question 3 confirm that the health care
risk factors method does not have high specificity in terms of identifying CA-MRSA.
Also the MRSA profile generated from the health care risk factors method from research
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question 1 showed that only 40 out of 70 (57.14%) of those designated as CA-MRSA by
genotyping were also identified as CA by phenotyping. This was highlighted in Figure 4,
which is a graphical representation of the correctly identified HA-MRSA versus CAMRSA distribution generated for each phenotyping method, compared to the genotyping
results. To further consider the ability of each of the three phenotyping methods to
correctly identify a MRSA case as CA-MRSA, I produced a ROC curve, presented in
Figure 5, which clearly shows that the susceptibility method is more sensitive than either
of the other two phenotyping methods and therefore has more utility in correctly
identifying a MRSA case as CA-MRSA. This is again compatible with the findings from
Research Question 1 and 2.
The multivariate binary logistic regression analyses in response to Research
Question 4 were also consistent with my other findings for the previous three research
questions. In this case, both the block method and the backward conditional method
showed that the susceptibility pattern phenotyping variable was significantly more
predictive than either of the other two phenotyping methods. By contrast, for both the
health care risk factor and the infection type phenotyping methods, the 95% CI include an
OR of 1, suggesting that when results of either of these methods are coded ‘1’ for HAMRSA, it is no more likely that the genotyping method will also give a HA rather than a
CA result, or when it is coded ‘0’ for CA-MRSA, it is again no more likely that the
genotyping method will also give a CA rather than a HA result.
In using the block entry multivariate binary logistic regression method, I tested
the strength of each block using both the Cox & Snell and the Negellkerke R Squares
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(Table 20). It emerged that the largest change for each Pseudo R Square test occurred
after the addition of block three, which is the antibiotic susceptibility method. This again
confirmed the utility of using this phenotyping method to accurately classify MRSA
according to a genotyping gold standard as opposed to either of the other two
phenotyping methods. Further confirmation was obtained when I used chi square in the
Homer and Lemeshow Test of Model Fit to compare the results expected based on the
model to those actually observed (Table 21) indicating that both the block containing
antibiotic susceptibility pattern and the block containing the variables gender, admission
profile and pre-existing illness (Table 18) could contribute to a useful model for
prediction of MRSA type.
This was clarified when I used a reduced model by the backwards conditional
method. Of the variables included in the reduced model, only admission profile had an
OR whose 95% CI did not include 1. The results of the comparison of the Cox & Snell
and Negelkerke R Squares calculated with each model iteration using the backwards
conditional method show that neither of these Pseudo R Square tests change significantly
through each iteration, as might be expected as the most predictive variables, i.e.
susceptibility pattern phenotyping and admission profile, remain in each iteration.
The data I generated in response to Research Question 4 identified a reduced
model, using the variables susceptibility method phenotyping and admission profile, as
effective in prediction of HA-MRSA and CA-MRSA as defined by a genotyping gold
standard. The theoretical basis of this study relied on both ecological theory and ASP
theory. The ecological theory would favor HA-MRSA in a health care environment,
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where the use of antibiotics is common. HA-MRSA usually carries either SSCmec II or
III, which have acquired genes for resistance to antibiotic classes beyond the β-lactams
(Hiramatsu et al., 2002). CA-MRSA, on the other hand, tends to carry SSCmec IV and V,
which are relatively small, leaving it potentially susceptible to clindamycin and other
non-β-lactam antibiotics (Naimi et al., 2003). The emergence from Research Question 4
of the antibiotic susceptibility method and hospital admission profile as strong predictors
for the classification of HA-MRSA versus CA-MRSA is therefore consistent with
ecological theory. However, caution is always needed, as the classification of ‘HAMRSA’ and ‘CA-MRSA’ has been challenged by studies showing that MRSA isolates
characterized as containing SCCmec IV and PVL, thus genotypically ‘CA-MRSA’, are
arising in the health care environment (David et al, 2008a). For example in Saudi Arabia,
a case has been reported in which a CA-MRSA strain was transmitted directly from a
father to his child in a neonatal intensive care unit (Al-Tawfiq, 2006). A genotypic
analysis of 107 MRSA isolates from King Fahad Medical City in Riyadh, Saudia Arabia
also revealed a high prevalence of PVL-expressing strains, normally considered to be an
indicator of CA-MRSA (Monecke et al., 2012). Thus, the relatively limited information
available on MRSA profiles in Saudi Arabia health facilities is consistent with
international experience of crossover of CA-MRSA strains into hospitals and other health
care settings (David et al, 2008a; Monecke et al., 2012). The combination of the
antibiotic susceptibility with the admission profile, as proposed from my results in
response to Research Question 4, should be effective to help avoid erroneous
classification of CA-MRSA in health care settings as HA-MRSA. The high specificity
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identified for the antibiotic susceptibility method in Research Question 3 is reassuring in
this context.
By contrast, in the multivariate logistic regression analysis in Research Question
4, the health care risk factors phenotyping did not emerge as predictive of genotyping
classification results. Genotyping methods such as multiplex PCR are highly reliable in
classifying MRSA (Stefani et al., 2012). It is therefore important to identify reliable
phenotyping criteria that have been independently confirmed with genotyping results.
The results for Research Question 3 and 4 of my study, demonstrating the concordance
and predictive value of the antibiotic susceptibility pattern method for genotyping
classification, are consistent with other studies showing concordance between antibiotic
susceptibility phenotyping and genotyping and/or poor predictability of the health care
risk factors method (Campanile et al., 2011; David et al, 2008a.; Donnio et al, 2004;
Hetem et al., 2012; Maree et al., 2007; Nair et al., 2011; Otter & French, 2011; Song et
al., 2011). In East Asia, there is evidence of spread of ‘HA-MRSA’ and ‘CA-MRSA’
from the community to the hospital and vice versa (Song et al., 2011). In the current
study, the suitability of the three phenotyping methods in the Saudi Aramco community
from the Eastern province of Saudi Arabia, was considered in comparison to a ‘gold
standard’ genotyping multiplex PCR method. Genotyping by this method took into
account some of the mobile genetic elements of Staphylococcus aureus that have driven
the emergence of MRSA, i.e. PVL and mecA, which are key to how HA-MRSA and CAMRSA fit into both the ecological and antibiotic selection pressure framework. Thus, the
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concordance of the susceptibility method with the multiplex PCR genotyping method
further confirmed its consistency within the theoretical framework of the study.
While based on the conservative definition of HA-MRSA, CDC estimates suggest
that up to 85% of MRSA infections would be classified as HA-MRSA (CDC, 2005), the
genotyping results of my study suggest a much more even distribution. Results of
previous studies in MRSA assignment in Saudi Arabia have shown that communityacquired infections comprised 62% (Al‐Tawfiq, 2006). The proportion of CA-MRSA
dramatically increased from 41.7% in 1999 to 66.6% in 2002 (Bukharie, 2010a, p. 379).
In my study, genotyping analysis in the Saudi Aramco sub-population indicated that CAMRSA lies somewhere in between these figures at 70 out of a total of 113 (52.6%) of
MRSA infections (Table 9). For men, the percentage is lower, as 28 out of the total 69
men (40.6%) were identified as having CA-MRSA, while for women it is higher as 42
out of the total of 64 women (65.6%) were identified as having CA-MRSA (Table 9).
This is not entirely consistent with previous studies in which the proportion of males with
CA-MRSA tends to be significantly higher, particularly in urban areas, due for example
to factors such as their greater likelihood of engaging in contact sports (Cooke & Brown,
2010; Davis et al., 2007; Hidron et al., 2009; Thomas et al., 2007). While gender did not
emerge as a predictive variable in the logistic regression analysis, this data suggests that
gender may yet be relevant in CA-MRSA and HA-MRSA distribution; consideration of
larger groups of patients over time should clarify the point.
A combination of antibiotic susceptibility pattern and hospital admission profile
emerged as the suggested model for phenotyping classification of MRSA in the Saudi
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Aramco population. This finding is consistent with both the theoretical framework
presented and the literature reviewed in chapters 1 and 2.

Limitations of findings
The study was limited due to the ever-changing molecular characteristics of
MRSA from geographical and temporal perspectives, particularly the evolutionary
success of CA-MRSA strains that makes their growth rates 1.33 faster than HA-MRSA
strains (D'Agata, Webb, Horn, Moellering & Ruan, 2009). Therefore, the profile
generated for samples collected in 2012 and 2013 may not be the same as the profile that
exists currently. However, the concordance of the proposed phenotyping characterization
based on prediction of genotyping results should minimize the impact of this limitation.
Phenotyping by any of the recognized common methods is complicated by factors
including emergence of invasive and multidrug resistant CA-MRSA strains in health care
settings as a cause of health care associated infection (Gillet et al, 2010; Seybold et al,
2006), as observed both in the USA (David et al, 2008a; Maree et al., 2007; Nair et al.,
2011; Otter & French, 2011) and in Europe (Campanile et al., 2011; Donnio et al., 2004;
Hetem et al., 2012) and in Saudi Arabia itself (Monecke et al., 2012), and also increased
circulation of HA-MRSA in the community (Miller et al, 2007; Seybold et al, 2006).
This study was limited to patients attending the Aramco Dhahran Health Center,
an acute-care hospital in Dharan, in the Eastern Province of Saudi Arabia. While these
patients were a representative sample of the study population, i.e. approximately 350,000
people who are employees, dependents or annuitants of the Saudi Aramco energy
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corporation, which is headquartered in Dhahran (Saudi Aramco, 2014), they may not be
representative of Saudi Arabia as a whole.
Recommendations
As this study was confined to a sub-population and results may not necessarily be
representative of the country as a whole, future studies should focus on a nationally
representative sample of hospitals and other health care facilities in Saudi Arabia. In
addition, similar studies comparing phenotypic methods of classifying MRSA as HAMRSA or CA-MRSA to a gold standard genotyping technique should be performed in
hospitals and other facilities, such as long-term care facilities, in all regions of the
country. In this way, locally, regionally, and nationally applicable sets of phenotyping
variables could be adopted appropriate to urban versus rural areas or different types of
health care settings (Stefani et al., 2012)..
Saudi Arabia currently lacks a MRSA national control program. If appropriate
phenotyping variables verified against gold standard genotype classification were
identified in institutions across the country, it would inform potential implementation of
the expert advice. This suggests that within countries there should be three levels of
typing laboratories at local, regional, and national levels (Stefani et al., 2012). These
laboratories should play different roles and be set up to perform typing techniques within
their scope with regards to function and available resources (Stefani et al., 2012). This
type of practical and reliable classification scheme, adapted to be applicable to Saudi
Arabia rather than imported from other countries, will assist in beginning to harmonize
surveillance and treatment programs.
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In this study, hospital admission profile emerged as a predictive variable in
determining MRSA status. This finding should be further examined in the context of
other health care facilities to determine if the result was unique to the Aramco Dhahran
Health Center or if it is a general phenomenon in other hospitals in Saudi Arabia.
Likewise, the general applicability of the antibiotic susceptibility method of phenotyping
in predicting MRSA status needs to be determined.
Long term studies of the susceptibility pattern and hospital admission profile
should be performed in the Aramco Dhahran Health Center and periodically checked
against the Multiplex PCR screening method, to confirm the long-term robustness of the
these two variables in accurately predicting MRSA status. This is of particular
importance in view of the constant evolution of CA-MRSA antibiotic resistance profiles,
which might also complicate findings from the susceptibility pattern classification of
MRSA. These concerns are even more relevant given the rise of CA-MRSA in Saudi
Arabia (Bukharie, 2010a, p. 379).
In this study, the genotyping analysis in the Saudi Aramco sub-population for
men suggested that the majority of MRSA infections were HA-MRSA; 28 out of the total
69 men (40.6%) were identified as having CA-MRSA (Table 9). For women the opposite
was the case; 42 out of the total of 64 women (65.6%) were identified as having CAMRSA (Table 9). While gender did not emerge as a predictive phenotyping variable in
the logistic regression analysis, the difference in gender distribution of HA-MRSA and
CA-MRSA in my data suggests that gender may be relevant in CA-MRSA and HAMRSA distribution in Saudi Arabia. Expansion of studies to cover larger areas of the
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country, with larger numbers of people and more institutions included, should clarify
whether this type of distribution is consistently observed and has any statistical
significance. This possibility should be pursued in any future studies covering other
centers and/or data collected over a longer timeframe.
In terms of implications for practice, the underlying reason for this research study
was the development and testing of a rapid, efficient, inexpensive, and reliable method of
identification of HA-MRSA and CA-MRSA strains circulating in the region. From the
results of the study, I recommend that a phenotyping method based on antibiotic
susceptibility pattern and hospital admission profile be tested with a view to replacing the
existing health care risk factors phenotyping that is currently most common, if this new
method proves to be robust in the longer term. Results of the concordance analysis
suggest, specificity analysis and multivariate logistic regression suggest that the health
care risks factor and infection type methods should be discarded as phenotyping methods
in this population. It is also important to consider that the theory of antibiotics pressure is
useful in explaining why some CA-MRSA strains are becoming resistant to different
groups of antibiotics, which might also interfere with the susceptibility pattern
classification of MRSA. The minor discordance between the suggested combination of
antibiotic susceptibility profiling and hospital admission profile for MRSA phenotyping,
compared to the genotyping analysis, suggests that it would be of benefit to carry out
genotyping analysis every two or three years to compare to and verify the new proposed
phenotyping method.
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Implications for Social Change
The goal of MRSA management programs at any health care facility is the
reduction of spread of the disease and hence reduction of the burden of high medical
costs and reversal of the increasing trend of MRSA morbidity and mortality. The results
of this study have identified phenotyping variables that can be applied to distinguish
between HA-MRSA and CA-MRSA and hence gauge distribution for each MRSA type,
seasonality, and potential shifts in therapeutic drug resistance. This should help in the
formulation of prevention strategies to reduce MRSA transmission and help in
understanding and preventing MRSA outbreaks through comparative analyses of data
from previous studies worldwide. Such comparative analyses will also advance
knowledge on genetic, epidemiological, and clinical characteristics.
The results of my study have implications for positive social change in that
antibiotic susceptibility pattern and hospital admission profile have been identified as
variables that could form the basis of an MRSA screening program for the Saudi Aramco
population. This has the potential to be extended to the Eastern Province of Saudi Arabia,
where the Aramco Dhahran Health Center is situated. A reliable and affordable MRSA
screening program based on concordance of phenotyping classification with a genotyping
gold standard would provide a rational basis for MRSA surveillance and characterization
and effective targeting of therapies, as well as education of health workers, in Saudi
Arabia. Extending the findings of this study to other health care facilities throughout the
country would potentially contribute to the development of such a screening program.
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Conclusions
The purpose of this study was to identify which of the three phenotyping methods,
health care risk factors, infection type and antibiotic susceptibility pattern, or
combination thereof, was best able to characterize the MRSA strains with reference to the
profile generated using a Multiplex PCR genotyping method, within the Saudi Aramco
community. An additional goal was to help identify the phenotyping variables which
were most predictive of genotype and provide an accurate method for development of an
effective screening, prevention, control, and treatment program in this population.
Accurate phenotyping and the ability to rapidly and efficiently assign MRSA cases to
HA-MRSA or CA-MRSA is vital for monitoring trends in MRSA within health care
settings and in the community and making choices of appropriate antibiotic treatment,
outbreak monitoring, and prediction or recognition of epidemics.
MRSA is on the rise. I carried out the study against a background of rising levels
of MRSA in Saudi Arabia, bringing a high financial costs in morbidity and mortality
burdens (Bukharie, 2010). The results of my study suggest a potential phenotyping-based
method, built on antibiotic susceptibility pattern and hospital admission, with which
MRSA could be accurately identified as HA-MRSA and CA-MRSA. As these have
different genetic properties which confer different antibiotic sensitivities and virulence
properties, the availability of such a method would assist in effective diagnosis and
tailoring of therapy. For an effective screening and surveillance program and effective
therapy it is vital that a reliable and affordable screening method suited to local
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conditions is available. My study lays a foundation on which such a screening method
could be built.
Epidemiology of MRSA varies widely between countries (Maree et al., 2007; Pan
et al, 2003 & 2005; Labandeira-Rey et al., 2007; Song et al., 2011; Stefani et al., 2011;
Tietz, Frei, & Widmer, 2005). The current screening practices in Saudi Arabia depends
on the use of phenotyping methods validated for hospitals in the United States (Bukharie,
2010). Thus, the health care risk factor phenotyping method is the most commonly used
in the Johns Hopkins Aramco Hospital. However, no unified method has been adopted
and the recognized discrepancies in MRSA classification between phenotyping methods
have not been taken into consideration (Devita, Lawrence, & Rosenberg, 2009; Sievert,
2008).
The results of my study show that the health care risk factors method is unsuited
to the correct classification of MRSA within this community, particularly in regard to
CA-MRSA identification. According to the results generated in response to my Research
Question 1, only two thirds of the cases designated as CA-MRSA by genotyping were
also identified as CA by health care risk factors phenotyping. The total was even lower
for infection type phenotyping, for which only 37.14% of cases designated as CA by
genotyping were also identified as CA by infection type phenotyping. By contrast, most
of the cases designated CA by genotyping were also recognized as CA by susceptibility
pattern phenotyping.
The results generated in response to my Research Question 2 confirmed that the
susceptibility pattern method was the most discordant of the three methods. Consistent
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with these results for Research Question 1 and 2, the data I generated in response to
Research Question 3 confirmed that the susceptibility pattern method was significantly
more specific for identification of CA-MRSA than either of the other two phenotyping
methods. Of several variables tested in this study, I confirmed in response to my
Research Question 4 that the antibiotic susceptibility pattern phenotyping method, in
combination with hospital admission profile, is the most predictive of MRSA
classification obtained by Multiplex PCR genotyping in a sample of the Saudi Aramco
population.
My study has fulfilled the original purpose of characterizing the MRSA strains
within the Saudi Aramco community and accurately identifying MRSA strains as HAMRSA or CA-MRSA by comparing and contrasting the three existing phenotyping
methods against a gold standard Multiplex PCR method. It has also fulfilled the goal of
helping to identify the phenotyping variables which were most predictive of genotype and
provide an accurate method for development of an effective screening, prevention,
control, and treatment program in this population. It has led to the identification of the
antibiotic susceptibility pattern phenotyping method in combination with hospital
admission profile as the potential basis of a reliable, inexpensive, and readily usable
phenotyping classification method, validated against a genotyping gold standard, for
determination of distribution of HA-MRSA and CA-MRSA in the Saudi Aramco
community. Based on my study results, I therefore recommend that a phenotyping
method based on antibiotic susceptibility pattern and hospital admission profile should be
tested in this community with a view to replacing the existing health care risk factors
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phenotyping that is currently most common, if this new method proves to be robust in the
longer term. Furthermore, I recommend that similar studies should be carried out in other
communities and settings across Saudi Arabia with a view to establishing a national
phenotyping program underpinned by comparison of phenotyping data to a genotyping
gold standard.
The study facilitated a more comprehensive understanding of epidemiological
characteristics of MRSA in Saudi Arabia. The standardized phenotyping technique
identified in this study to classify MRSA infections as either HA-MRSA or CA-MRSA
will provide new evidence to facilitate targeting of control efforts and preventive
methods, which will better contend with this adept and evolving bacterial organism.
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Appendix A: Multiplex PCR Methodology
The primers for the amplification of the mec-A gene and pvl gene were MECAP4
(5'-TCCAGATTACAACTTCACCAGG-3') and MECAP7 (5'- CCACTTCATATC
TTGTAACG-3'), as described by Oliveria et al. (2002), and luk-PV-1 (5'ATCATTAGGTAAAA TGTCTGGACATGATCCA-3') and luk-PV-2 (5'- GCATCAA
GTGTATTGGATAGCAAAAGC-3'), as described by McLure et al. (2006), respectively.
PCR was performed using a Qiagen Multiplex PCR kit (Hilden, Germany) with the
following slight modifications. A 25-μl final reaction volume consisted of 12.5 μl
mastermix, 2.5 μl primer mix (0.2 μM of each primer), 3 μl DNA template and 7 μl
RNase free water. DNA samples were subjected to thermocycling conditions with an
initial inactivation step (95o C, 15 min), 35 repetitions of a three-step cycle of
denaturation (94o C, 30 sec), annealing (60o C, 90 sec) and extension (72o C, 90 sec)
with a different final extension (72o C, 10 min) and a step that involved soaking at 4oC.
After these steps, 5 μl of amplified products were mixed with 2 μl of ethidium bromide
(Fermentas, St. Leon-Rot, Germany) and loaded on a 2% agarose gel (Amresco, Solon,
USA) along with GeneRuler TM 100 bp Plus DNA Ladder (Fermentas, St. Leon-Rot,
Germany); electrophoresis was performed at 100 volts for 50-60 min and visualized
under a UV transilluminator (Bio-Doc analyzer, Biometra, Goettingen, Germany).

